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ABSTRACT
THE ROLE OF GLYCOCONJUGATES IN MEDIATING HUMAN
SPERM-EGG BINDING AND IN THE INDUCTION OF FETOMATERNAL TOLERANCE
Manish Suresh Patankar
Old Dominion University and Eastern Virginia Medical School, 1998
Director: Dr. Gary F. Clark

Using the hemizona assay (HZA), a in vitro sperm-egg binding assay, we show
that specific glycoconjugates known to inhibit immune cell interactions mediated by the
selectins, potently block human sperm-egg binding. The selectin ligand sialyl Lewis*
inhibits sperm binding in the HZA by 60% at a concentration of 1 mg/ml. Our data
indicates that glycodelin-A, a endometrial glycoprotein known to block sperm-egg binding
in the HZA at low concentrations expresses unusual fiicosylated lacdiNAc type glycans.
The fiicosylated lacdiNAc type sugars have been previously shown to be 15-20 fold more
potent ligands of E-selectin. Glycodelin-S a seminal plasma glycoform of glycodelin-A
does not express such unusual glycans and is not contraceptive. These results support our
hypothesis that human sperm-egg binding may involve a selectin-like event.
Periodate oxidation under conditions that affect only the terminal sugar residues
results in a 30-40% loss in sperm binding. Treatment of the ZP with neuraminidase and
endo-P-galactosidase results in a 2.5 and 4 fold enhancement in sperm binding
respectively. However, sequential treatment of the ZP with neuraminidase and periodate
results in 80% decrease in sperm binding. These studies strongly indicate that ZP glycans
are essential for mediating human gamete binding. Furthermore, efficient initial human

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

sperm egg binding in vivo may require a prior activation event involving desialylation of
the gametes.
In this study we provide preliminary evidence that human gametes express the
bisecting type glycans. Our studies indicate that these glycans potently inhibit natural killer
(NK) cells, the predominant cell type expressed in the uterus during pregnancy. Other
glycoconjugates like a-fetoprotein, expressed in the uterus during pregnancy, also carry
the bisecting-type glycans. Based on these observations we propose that glycoconjugates
expressed during pregnancy protect are responsible for mediating feto-matemal tolerance.
We refer to this model for as the Human Feto-Embryonic Defense System hypothesis.
Finally our data suggests that parasites like schistosomes, filarial worms, and the human
immunodeficiency virus may be evading the host’s immune responses by a similar by
expressing immunosuppressive glycoconjugates on their coats.
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CHAPTER I
INTRODUCTION

Review o f the Literature
Carbohydrates constitute a major component of the diverse biopolymers expressed
in both the animal and the plant kingdom. These sugar chains are either found as free
oligosaccharides or may be attached to lipid (glycolipids) or protein (glycoproteins)
backbones. Such oligosaccharide bearing chimeric molecules are referred to as
glycoconjugates. The main purpose of this research is to examine the role of carbohydrates
in mediating human fertilization and human pregnancy. A brief review of the chemistry and
biochemistry and the possible biological roles of carbohydrates in mammals are provided to
acquaint the reader with the various aspects of carbohydrate biology (commonly referred to
as glycobiology) and to review the latest developments in this field.
Biosynthesis o f Oligosaccharides
The most common type o f monosaccharides found in mammals are L-fucose (Fuc),
D-glucose (Glc), D-galactose (Gal), D-mannose (Man), D-A-acetylglucosamine (GlcNAc),
D-A’-acetylgalactosamine (GalNAc), and A-acetylneuraminic acid (NeuAc; also known as
sialic acid) (Figure 1). These sugars are linked to each other via (9-glycosidic bonds to form
the oligosaccharides. Synthesis of the oligosaccharide chains of glycolipids or glycoproteins
is initiated in the endoplasmic reticulum of the

cell and is completed in
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Figure 1: Structures of monosaccharides commonly found in mammalian glycans. The
names and abbreviations commonly used for these sugars are given.
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the irons compartment of the Golgi apparatus. Two components that are absolutely
essential for the synthesis of oligosaccharide chains are the glycosyltransferases and the
sugar nucleotides. Glycosyltransferases are enzymes that catalyze the addition of the
monosaccharide units to the growing oligosaccharide chain (Paulson and Colley, 1988).
For this reaction the glycosyltransferases require sugar nucleotides as the source for the
monosaccharide units. Sugar nucleotides carry a monosaccharide attached to the nucleotide
via a high energy phosphate bond. The energy required for the addition of the
monosaccharide to the oligosaccharide chain is provided by the hydrolysis of this high
energy bond. The nucleotide sugars used as substrates by the different types of
glycosyltransferases are listed in Table 1.
Many different types of glycosyltransferases have been identified and characterized
to date (Paulson and Colley, 1988). The glycosyltransferases are named according to the
monosaccharide that they add to the oligosaccharide chain that is being synthesized. Thus
enzymes that add Gal to the growing sugar chain are termed as the galactosyltransferases
(Gal-T), whereas those adding a GlcNAc residue are iV-acetylglucosaminyltransferases
(GlcNAc-T). Glycosyltransferases are further classified according to the linkage position to
which the monosaccharide unit is being added. For example, a fucosyltransferase (Fuc-T)
that adds a Fuc residue to the oligosaccharide in the a l-3 position is termed as the al-3
Fuc-T, whereas the enzyme that adds a Fuc in the a 1-2 linkage is referred as the a 1-2 FucT. Approximately 100 or more different glycosyltransferases are required for the synthesis
o f all of the known carbohydrate structures on glycolipids and glycoproteins (Paulson and
Colley,

1988).

Table 2

shows the commonly found glycosyltransferases that
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Table 1: Nucleotide sugars used as donor substrates by different glycosyltransferases.

Glycosyltransferase

Nucleotide Sugar Substrate (Abbreviation)

Glucosyltransferases

Uridine diphosphoglucose (UDP-GIc)

Galactosyltransferases

Uridine diphosphogalactose (UDP-Gal)

Mannosyltransferases

Guanidine diphosphmannose (GDP-Man)

N-Acetyl-

Uridine diphospho-N-acetylglucosamine

glucosaminyltransferases
N-Acetylgalactosaminyltransferases

(UDP-GlcNAc)
Uridine diphospho-N-acetylgalactosamine
(UDP-GalNAc)

Fucosyltransferases

Guanidine diphosphofiicose (GDP-Fuc)

Sialyltransferases

Cytidine monophosphoneuraminic acid
(CMP-NeuAC)
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Table 2: Some o f the glycosyltransferases that are required for the synthesis of terminal
sugar residues.

Glycosyltransferase
Galactosyltransferase (Gal-T)
GlcNAcP 1-4-Gal-T
Galal-3-Gal-T

Sequence Formed
Gaipi-4GIcNAcGalal-3Gaip l-4GlcNAc-

Sialyltransferase (ST)
Galcx2-3-ST
Gala2-6-ST
Fucosyltransferase (Fuc-T)
Galal-2-Fuc-T
GlcNAca 1-3/4-Fuc-T

NeuAco2-3Gaip l-4GlcNAc
NeuAca2-6Gaip 1-4GlcNAc

F ucal-2Gaip 1-4GlcNAcGaip l-4(Fucal-3)GlcNAcGaip l-3(Fucal-4)GlcNAc-

A'-Acetylglucosaminyltransferase (GlcNAc-T)
GlcNAc-T I

Manal'6>M anal-6
Manal-3
^>Manpi-4GlcNAcpl-2Manal-3
GlcNAcpl-2Mana 1-6

GlcNAc-T E

GlcNAc-T m

>M anpi-4-

GlcNAcpi-2Manal-3
GlcNAc P1-2Mana 1-6
s
GlcNAcpl-4 —Manpl-4GlcNAcP l-2M anal-^

A'-Acetylgalactosaminyltransferase (GIcNAc-T)
Gala l-3GalNAc-T

Fucal-2(GalNAcal-3)Gal-

GlcNAcP 1-4GalNAc-T

GalNAcpi-4GIcNAc-
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are required for the synthesis of the terminal sugars. The sequence specificities o f the
glycosyltransferases are also shown.
Different Types o f Mammalian Glycoconjugates
(a) Glycoproteins
Oligosaccharides conjugated to the protein backbone are of two major types, the Nlinked and the CMinked oligosaccharides (Komfeld and Komfeld, 1985; Olofsson, 1991) .
The AMinked oligosaccharides are attached to the protein via an asparagine (Asn) residue
whereas the O-linked chains are conjugated via serine (Ser) or threonine (Thr) residues of
the protein. The Asn residue o f a protein flanked by an -X-Ser/Thr (where X is any amino
acid) sequence is usually a good consensus site for A-glycosylation (Komfeld and Komfeld,
1985). However, not all Asn residues in this Asn-X-Ser/Thr motif are TV-glycosylated. No
consensus sequence has been shown to exist for the O-glycosylation sites. The typical
structures of the N- and CMinked oligosaccharides are shown in Figure 2.
Biosynthesis of the 0-linked chain is initiated by the addition of a GalNAc to the
Ser or Thr residue of the protein (Olofsson, 1991). This reaction is followed by the
sequential

addition

of the

other

monosaccharide

units

by

the

appropriate

glycosyltransferases. Recently however, an unusual modification of some proteins has been
reported where Ser or Thr residues are modified by a single GlcNAc. The (3-linked
carbohydrate chains may range in size from one to more than 20 sugars with the larger
oligosaccharides displaying considerable structural and antigenic diversity (Olofsson,
1991). Typically the CMinked oligosaccharides are expressed in clusters o f heavily
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Figure 2: Structures o f some of the commonly found iV-linked and 0-linked glycans in
mammals. Structures shown in Panel A-C are complex type, hybrid type, and high
mannose type A'-Iinked sugars. Panel D and E show structures of CMinked glycans found
on erythrocyte surface glycoproteins.
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glycosylated domains of the protein. Mucins are a classic example of proteins carrying
heavily (9-glycosylated domains. Two O-linked oligosaccharides expressed on human
erythrocyte membrane glycoproteins are shown in Figure 2.
N-linked oligosaccharides are broadly classified into the complex type, hybrid, and
high mannose type structures (Figure 2). The basic core of Ar-linked oligosaccharide is
initially synthesized on a lipid named dolichol (Komfeld and Komfeld, 1985). The core
structure is then transferred en block to the Asn residue of the protein by a specific
oligosaccharidyl transferase enzyme. The core structure is further modified by addition and
deletion of specific monosaccharide units in the endoplasmic reticulum and Golgi
apparatus, to produce the final structures shown in Figure 2.
(b) Glycolipids:
Glycolipids are synthesized by the sequential addition of the sugars to a lipid core.
Glycolipids are typically found in animal cells have a sphingosine backbone. These
glycolipids are referred to as the glycosphingolipids (GSL) (Basu and Basu, 1982). The
GSL are widely distributed in animal tissues, particularly the synaptic membranes and cell
surfaces. Most commonly occurring GSL’s can be classified into two different families (a)
the acidic or NeuAc containing GSL’s also known as gangliosides, and (b) the neutral
GSL’s containing mono-, di-, or oligoglycosyl chains attached to the ceramide backbone.
Gangliosides may contain one or more NeuAc residues. The neutral polyglycosyl GSL’s
are further subdivided into two classes, (a) the blood group active GSL’s which contain a
core structure of GlcNAcpi-3Gaipi-4Glcpi-lCeramide, and (b) the globosides whose
core

structure

is

Galal-4Gaipi-4GlcP 1-1 Ceramide

(Table

3).

Many
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II

Table 3: Structures o f different mammalian glycolipid glycans.

STRUCTURE

NAME

Gangliosides
Glcpl-lCer

Glucosylceramide

Galpl-4Glcpi-lCer

Lactosylceramide

NeuAca2-3Galp MGlcp 1-lCer

GM3

GalNAcP l-4Gaip MGlcP 1-lCer
GM2
NeuAca2-^
Galp l-3GalNAcP l-4Galp l-4GlcP 1-lCer

GM1

NeuAca2-^
GalNAcpi-3

I

NeuAca2-8Gaip 1-4GlcP 1-1Cer

GD2

I

NeuAcot2-3

Blood Group Active
Fucal-2(Galpl-4GlcNAcpi-3)nGaipi-4Glc-pl-lCer

Gala 1-3
I
Fucal-2(Gaipi-4GlcNAcpl-3)nGaipi-4Glc-pl-lCer

Blood Group Ht (n=l)
Hn (n=2)

Blood Group Br (n=l)
Bn (n=2)

GaINAcal-3
Fucal-2(cjalpl-4GlcNAcpl-3)nGaIpl-4Glc-pl-lCer

Blood Group Af (n=l)
An (n=2)

Globosides
Galal-4Gaipi-4Glcpl-lCer
GaINAcpl-3Galal-4GaIp MGIcp 1-lCer
GalNAcal-3GalNAcp l-3Galal-4Gaip l-4Glcp 1-lCer

GbOse3Cer
GbOse4Cer
GbOsesCer/
Forssman
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glycosyltransferases that are involved in the synthesis of glycoprotein glycans are also used
for GSL oligosaccharide synthesis.
Glycoforms
The final products of glycosylation linked to a single protein are very diverse.
Studies indicate that a significant number of the molecules o f a glycoprotein may not have
the fully formed oligosaccharide chain. For example porcine fibrinogen carries two different
forms of oligosaccharides (Figure 3) (Da Silva et al., 1994). A single glycoprotein is
homogenous in its protein component but usually heterogeneous in its carbohydrate
sequences. A subset of glycoprotein molecules that are homogeneous in both their protein
and carbohydrate sequences is referred to as a glycoform. Therefore a single glycoprotein
generally consists of a mixture of different glycoforms (Rademacher et al., 1988).
Biological Roles fo r Oligosaccharides
In recent times, considerable effort has been devoted to understanding the chemistry
and biochemistry of glycoconjugates. However, determining the exact physiological roles
of these molecules has remained enigmatic. Carbohydrates have been conventionally known
to affect the three dimensional structure of proteins (Varki, 1993). Therefore glycans have
been postulated to play a major role in determining the folding patterns of proteins. It has
been reported recently that simple occupation of key glycosylation sites may be the critical
factor regulating protein folding in certain cases (Helenius, 1994; Allen et al., 1995; Feng et
al., 1995). For example, occupancy of crucial N-linked glycosylation sites by a single
monosaccharide (GlcNAc-Asn) is sufficient to allow proper folding of rat leutenizing
hormone receptor to occur (Zhang et al., 1995).
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Gaip 1-4G1cNA cPl-2Manal-6
ManP 1-4GlcNAcP 1-4GlcNAc-AsnNeuAca2-6-Gal-p l-4GlcNAcp l-2Manal-3

NeuAca2-6-Gaip 1-4GlcNAcP 1-2Mana

F ucal

- 6

1 - 6

ManP -4GlcNAcP 1-4GlcNAc-Asn1

NeuAca2-6-Gal-P 1-4GlcNAcP - Mana -/
1

2

1

F ucal

- 6

Figure 3: Two different glycans found on porcine fibrinogen.
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Another proposed role for carbohydrates is that, being hydrophilic molecules, they
help solubilize the proteins better in the intercellular and intracellular milieu (Varld, 1993).
While this proposed function may be a valid biological role for the carbohydrates, it is
difficult to understand the expression of structural diversity of the oligosaccharides in this
context. For example, if the sole purpose of expressing carbohydrates on proteins or lipids
was to increase the solubility of these molecules, it would have been more beneficial for the
cell to express only a few particular kinds of carbohydrate structures that could help
solubilization of the molecules. However, oligosaccharide structures reported so far in the
literature are extremely diverse. Furthermore, there have also been reports of the
oligosaccharides being modified by acetyl, glycolyl, sulfate, or phosphate groups (Varki,
1992; Komfeld et al., 1982). Thus each individual cell expends considerable effort in the
synthesis of the oligosaccharide structures, sugar nucleotides, and various enzymes like
glycosyitransferases and glycosidases involved in the synthesis and the degradation of
carbohydrates. It is in fact believed that an individual mammalian cell spends as much as 30
% of its total energy reserve on the synthesis of the oligosaccharides chains.
Few examples are available in the literature that conclusively demonstrate the
importance of carbohydrates in mediating any cellular event. Several studies implicating the
lack of oligosaccharide production or specific defects in the oligosaccharide processing
enzymes in various disease states have been reported. Examples of two such diseases are
discussed below to illustrate this point.
Carbohydrate-deficient glycoprotein syndrome (CDGS) is a family of multisystemic
congenital diseases which are caused due to the underglycosylation of glycoproteins. The
exact biochemical defect responsible for causing this disease has not been pinpointed.
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However, recent data suggests an abnormality in one of the steps of glycan assembly on the
protein (Charuk et al., 1993). Interestingly, one of the variants of CDGS (designated
CDGS II) has been linked to the deficiency of the GlcNAc-T II (Table 2), an enzyme
required for the synthesis of iV-linked oligosaccharides. Individuals suffering from CDGS
exhibit severe neurological and physical defects (Charuk, et al., 1993).
Tay-Sachs disease is another prominent example of the link between a deficiency of
a proper oligosaccharide processing enzyme and a disease state. Tay-Sachs disease is an
autosomal recessive disorder caused by inadequate activity of the enzyme (3-Nacetylhexosaminidase, used for degrading gangliosides in the brain. Gangliosides are found
in the highest concentration in the nervous system and are continually degraded by the
action of glycosidases, like P-N-acetylhexosaminidase (Mahuran, 1995). Deficiency o f this
enzyme results in the accumulation of the gangliosides in the brain of the infant suffering
from Tay-Sachs disease, resulting in severely retarded psychomotor development, impaired
vision and spasticity. Tay-Sachs disease is fatal usually before the infant is three years of
age.
However, such physiological disorders associated with either the lack o f or
incorrect expression or degradation of the oligosaccharide sequences do not provide
evidence for the functional role for carbohydrates in cellular events. It can still be argued
that the reason for these disorders is due to incorrect folding o f the proteins that bear the
aberrant oligosaccharides thereby inducing them to be inactive or to mediate abnormal
functions.
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The Selectins
In recent years more evidence has been presented suggesting a direct physiological
role for oligosaccharides in mediating many cellular events. Recruitment of the leukocytes
to the sites of inflammation has to occur under the influence of extremely high shear forces
generated by the high bulk rate o f flow of the blood cells in the postcapillary venules
(Lasky, 1995). However, such high shear forces do not prevent the tight binding of
leukocytes to the inflamed endothelium. The tight binding of these inflammatory cells has
been shown to be mediated by the cell adhesion molecules known as integrins. The slow
rolling of leukocytes on the surface of the inflamed endothelium occurs due to binding of
three specific carbohydrate binding proteins expressed on the surface of the leukocytes and
endothelial cells, with their respective ligands. These three receptors, E-, L-, and Pselectins have been identified and very well characterized (Lasky, 1995). E-selectin has
been found to be primarily expressed on the inflamed endothelium. P-selectin is expressed
in the a - granules of the platelets and the Wiebel-Palade bodies of the endothelial cells.
This selectin is rapidly translocated to the cell surface during inflammation. L-Selectin is
expressed on various leukocytes.
All three selectins carry a C-type lectin domain that can bind to a specific
carbohydrate ligand in the presence o f calcium (Lasky, 1995). The expression of the three
selectins is also differentially regulated. L-Selectin is constitutively expressed on the surface
o f the myeloid leukocytes and is rapidly shed by proteolytic cleavage after leukocyte
activation where it helps in mediating adhesion to high endothelial venules of peripheral
lymph nodes and to cytokine activated endothelial cells (Lasky, 1995). E-selectin is
synthesized by endothelial cells after stimulation with cytokines. Expression o f E-selectin

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

17

peaks 4 hours after stimulation and returns to basal levels within 12-24 hours. P-selectin is
rapidly translocated to the cell surface upon activation by agonists such as thrombin or
histamine. At the cell surface P-selectin serves as a receptor for the myeloid cells and
subsets of lymphocytes.
Considerable effort has been made to identify the exact ligand recognized by the
three selectins (Varki, 1994). Sialyl Lewisx (NeuAca2-3Gaipi-4[Fucal-3]GlcNAc), a
tetrasaccharide expressed on many glycoproteins and glycolipids has been shown to be a
ligand for the three selectins. Evidence supporting the role of sialyl Lewisx in mediating
adhesion include:
(1) Antibodies directed against sialyl Lewisx blocked cell adhesion mediated by both Eand P-selectins (Walz, et al., 1990; Phillips, et al., 1990; Polley, et al., 1991),
(2) Liposomes containing

glycolipids carrying the sialyl Lewisx epitope blocked

leukocyte adhesions to the inflamed endothelium (Lasky, 1995)
(3) All three selectins bind with differing affinities to immobilized glycolipids bearing
the sialyl Lewisx terminated glycans (Foxall, et al., 1992)
Substantial evidence suggests that sialyl Lewisx is a low affinity ligand for these
selectin molecules (Varki, 1994). Oligosaccharides bearing the sulfo-Lewisx (S03 '-3 Gaipi4[Fucal-3]GlcNAc-) and sulfo-Lewis* (S03 ‘-3 Gaipi- 3 [Fucal- 4 ]GlcNAc-) sequences on
their terminal ends also serve as ligands for the selectins. Other high affinity ligands have
since been identified. These high affinity ligands carry clusters of highly sialylated or
sulfated oligosaccharides which are responsible for serving as ligands for the selectins. In
addition to the presence of C-type lectin domain all of the three selectins also express a
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epidermal growth factor-like domain (Lasky, 1995). It is therefore likely that recognition of
the oligosaccharide ligand by the selectins could trigger a signal transduction cascade
through the epidermal growth factor-like domain. Such signaling events could in turn allow
tight binding of the lymphocytes to the inflamed endothelium via other receptors such as
the integrins.
The selectins have also proved to be excellent candidates for devising strategies for
the prevention of reperfusion injuries most commonly seen in patients with ischemia
(McEver, 1995). Efforts are under way to use sialyl Lewisx as a therapeutic agent for
blocking the recruitment of the leukocytes to the ischemic tissue thereby preventing these
injuries.
Other Mammalian Lectins
In addition to the selectins, a growing number of studies have indicated the
presence o f other mammalian lectins on the surfaces o f various immune effector cells and
also on neural cells (Varki, 1992). Recently, many different C-type and I-type lectins have
also been shown to be expressed on different immune cell types. I-Type lectins are specific
for sialic acids (Powell and Varki, 1995). CD22 is an example of an I-type lectin that is
expressed on the naive B-cells. Absence of CD22 on the naive B-cells results in
hyperactivation of the cells, suggesting that this molecule could play an important role in
the maturation process of the B-cells (O’Keefe, 1997). Recent reports suggest that the
ligand for CD22 is terminal NeuAca2-6Gaipi-4GlcNAc. Similarly, many C-type lectins
like CD94, and NKR-P1A have been shown to be expressed on natural killer cells and
various other T-cell subsets (Moretta et al., 1997).
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The exact physiological roles of many of these mammalian lectin receptors are
currently under intense scrutiny. However, the diversity o f the different oligosaccharide
chains expressed by the mammalian cells and the presence of specific carbohydrate binding
proteins strongly suggests that carbohydrates may be playing significant roles in various
physiological events. Research efforts currently undertaken by several groups in various
aspects of mammalian glycobiology will definitely help to determine the exact roles of the
glycoconjugates.
Role o f Carbohydrates in Reproduction
Another critical biological process that has been proposed to be mediated via
glycoconjugates is the initial binding of the male and female gametes (Bedford, 1977).
Studies performed in many different species throughout the animal kingdom have indicated
that specific carbohydrates expressed on the surface of the egg are recognized as ligands
for specific egg binding protein(s) expressed on the plasma membrane of the sperm.
Considerable evidence obtained by investigators using the murine model system also
strongly suggests the involvement of the carbohydrates in mediating mammalian sperm-egg
interaction (Wassarman, 1990). Mammalian eggs are surrounded by an extracellular matrix
referred to as the zona pellucida (ZP). During fertilization, sperm initially bind the ZP
before penetrating into the ooplasm. In the mouse, the ZP is primarily composed of three
glycoproteins, ZP1, ZP2 and ZP3 (Wassarman, 1988). Wassarman and co-workers have
demonstrated that carbohydrate chains expressed on ZP3 play a major role in mediating
murine sperm-ZP binding (Wassarman et al., 1986). Initial studies indicate that human
sperm-ZP binding is also mediated by the ZP glycans (Wassarman, 1990). However,
conclusive proof of the involvement of glycoconjugates in mediating human gamete binding
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has been lacking until recently. Initial studies performed by our group strongly suggested
that specific carbohydrate ligands could potently inhibit human sperm-egg binding (Mahony
et al., 1991; Oehninger et al., 1991; Patankar et al., 1993). These studies, reviewed in depth
in the introduction section of Chapter II, further indicate that the carbohydrate ligands
responsible for mediating human sperm-egg binding may also overlap with the same ligands
mediating human immune cell interactions (Patankar, et al., 1993). The purpose of the
current study was therefore to further investigate the validity of these initial observations
made in our laboratory.
Specific Aims o f this Study
(1) To conclusively determine if human sperm-egg binding is a carbohydrate mediated
event.
(2) To demonstrate the expression of carbohydrate sequences that could possibly play a
role in mediating immune cell interactions on the surface of the human gametes.
(3) To demonstrate that carbohydrate sequences expressed on the surface of the
gametes could affect immune cell function.
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CHAPTER II
INTRODUCTION

Fertilization of the female gamete is the first committed step in reproduction.
Mammalian fertilization is a multi-step process initiated by the binding of sperm to the egg.
This initial binding event results in fusion and subsequent transmission of genetic material
from parents to the offspring. Research performed using the mouse as the animal model
system has been helpful in providing considerable insights in the initial events leading to
fertilization. The understanding gained from these experiments and their impact on the
human gamete binding system is reviewed here.
Events Leading to Fertilization in Mice
The mammalian egg is surrounded by an extracellular matrix known as the zona
pellucida (ZP) (Figure 4). The sperm initially undergo loose attachment to the ZP. This
initial loose attachment is followed by a tight binding of the sperm to ZP. Tight adhesion of
the gametes is supposed to be mediated by the binding to the receptor expressed on the
surface of the sperm head to the ligands expressed on the ZP (Wassarman, 1990) (Figure
4). Lying beneath the surface of the sperm is an organelle referred to as the acrosome
(Figure 4). The acrosome is a lysosome-like body which contains proteases and
glycosidases. The tight binding of the sperm to the ZP results in fusion of the plasma
membrane with the outer acrosomal membrane, blebbing off of the fused membrane and
exposure of the inner acrosomal membrane (McLeskey et al., 1998). This process of fusion
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Figure 4: Mammalian gametes and major events occurring during fertilization. Panels A
and B show the important structural features of the sperm and the egg respectively. The
initial loose binding followed by tight adhesion and the penetration o f the sperm into the
egg is shown in Panel B.
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of the acrosomal membrane followed by the release of the acrosomal contents is known as
the acrosomal reaction. Proteases released in this step help the sperm to penetrate through
the ZP and reach the perivitelline space present between the ZP and the egg (Figure 4).
Once the sperm reach the perivitelline space, the plasma membranes of the gametes fuse
together to form the zygote.
Initial Sperm-ZP Binding
Considerable advances have been made in understanding the initial binding of
mouse sperm to the ZP. As discussed earlier the tight binding of the sperm to the ZP is
absolutely essential for the future events of fertilization to occur. A similarity between the
binding of leukocytes of inflamed endothelium and sperm-ZP binding is the presence of
high shear forces. Murine ZP3 has been isolated and purified from oocytes. Electrophoretic
studies indicate that this glycoprotein migrates as a diffuse band with an apparent molecular
weight of approximately 83 (kDa) (Wassarman, 1988). ZP3 has also been shown to be
sulfated and migrates on isoelectric focusing gels with an average pi of 4.7 (Shimizu et al.,
1983). Amino acid analysis of the ZP3 polypeptide chain indicates that it is composed of
402 amino acids with a calculated molecular weight of 44 kDa (Wassarman, 1988). ZP3
expresses 3-4 //-linked oligosaccharide chains and an undetermined number of O-linked
oligosaccharide chains (Salzmann et al., 1983). It has been accepted that the heterogeneous
nature of ZP3 observed during electrophoretic analysis of this glycoprotein is primarily due
to the posttranslational modification of this protein and not because of any heterogeneous
nature of the polypeptide chain.
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Several lines o f evidence have been presented suggesting that ZP3 mediates binding
o f sperm to the ZP:
(1) Initially it was observed that ZP3 purified form mouse oocytes bound specifically to
the sperm head and not the midpiece or the tail (Bleil and Wassarman, 1986). This
finding is consistent with the fact that only the head of the sperm is capable of
undergoing tight binding with the ZP
(2) Purified murine ZP3 does not bind to acrosome reacted murine sperm (Bleil and
Wassarman, 1986). This observation complements the data that the acrosome reaction
of the sperm is preceded by the tight binding of the gametes
(3) Purified ZP3 inhibits murine sperm-ZP binding at relatively low concentrations
(Florman and Wassarman, 1985) (Bleil and Wassarman, 1980) (Florman et al., 1984)
(4) Perhaps the most conclusive data demonstrating ZP3 as the primary receptor for the
sperm was obtained when it was shown that acrosome intact mouse sperm tightly
bound to silica beads coated with murine ZP3 (Vazquez et al., 1989)
(5) ZP3 was also shown to be capable of inducing acrosome reaction in murine sperm,
albeit at high concentrations (Bleil and Wassarman, 1983) (Florman, Bechtol et al.,
1984)
(6) ZP3 purified from mouse embryos did not bind to the heads of the mouse sperm
(Bleil and Wassarman, 1986). This observation is consistent with the fact that mouse
sperm do not undergo any attachment with the embryo. Thus considerable evidence has
been accumulated so far suggesting that at least in the murine model, sperm bind to the
ZP viaZP3.
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ZP3 Oligosaccharides Mediate Sperm Binding
As mentioned earlier, murine ZP3 has been shown to be heavily glycosylated. It was
initially reported that exposure o f ZP3 to high temperatures (100°C), or to denaturants like
urea and detergents like sodium dodecyl sulfate (SDS) did not significantly affect its ability
to serve as a sperm receptor (Bliel and Wassarman, 1980, Wassarman, 1985; Wassarman,
1989). Exposure to such harsh conditions usually results in denaturation o f proteins, in
turn resulting in the loss of their biological activities. Carbohydrates have however been
shown to be very resistant to such denaturing conditions. Therefore these initial
observations indicated that the oligosaccharide chains expressed on ZP3 could be playing a
role in mediating sperm-ZP binding. This suggestion perfectly complemented prior
observations that various monosaccharides, glycoconjugates, and lectins were capable of
abrogating the binding of the sperm to the ZP in the murine system in vitro (Huang et al.,
1982; Shur and Hall, 1982) (Oikawa et al., 1973) (Ahuja, 1982; Ahuja, 1985) (Shur and
Hall, 1982) (Lambert, 1984). It was further observed that some of the ZP3 glycopeptides
obtained upon digestion of the glycoprotein with pronase retained the ability to serve as
sperm receptor, although they were unable to induce acrosome reaction in the sperm
(Florman, Bechtol et al., 1984). More recently it was shown that the (9-linked and not the
//'-linked ZP3 oligosaccharides were absolutely essential for this molecule to serve as the
mouse sperm receptor (Litscher and Wassarman, 1996).
Further studies performed by Wassarman and co-workers indicated that a-linked
galactose at the nonreducing terminal of a subpopulation of the O-linked ZP3
oligosaccharides was absolutely essential for murine sperm-ZP binding (Wassarman, 1990).
Removal of this a-galactose by the enzyme a-galactosidase or by oxidation of the C-6

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

27

alcohol of this sugar to an aldehyde by galactose oxidase resulted in complete abrogation of
the sperm-receptor function of this oligosaccharide (Bleil and Wassarman, 1988). Recently
it has been shown that a synthetic oligosaccharide bearing a 1-3 linked galactose terminals
could effectively block binding of the murine sperm to the ZP (Litscher et al., 1995). Thus
there is considerable evidence to suggest that the oligosaccharides expressed on the murine
ZP3 are responsible for mediating sperm-ZP binding.
ZP3 is Found in A ll Mammalian Species
Studies performed to date have indicated that all mammalian species carry a
homolog of murine ZP3. ZP3 from many different species including the human have been
cloned and expressed in different cell types. The presence of ZP3 in all the mammalian
species indicates that the role of this molecule, i.e. in mediating sperm-ZP binding may have
been conserved in all of these species.
Human ZP3
As mentioned above, the human homolog of murine ZP3 has been cloned and
isolated. Based on the evidence obtained in the mouse system, it has been suggested that
the human ZP3 also may be playing a major role in mediating binding of sperm to the ZP.
However, the lack of significant number of human eggs has severely curtailed the ability to
isolate human ZP3 and to directly assess its potential as a sperm receptor as performed in
the mouse studies. To circumvent this problem, many researchers have attempted to obtain
recombinant human ZP3 (Chapman and Barratt, 1996). However, to date, a totally
biologically active ZP3 molecule has not been produced. It has been shown that
glycoproteins obtained using recombinant DNA technologies do not express the same
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biological activities, or at least not with the same potency. For example appropriate
expression o f the glycan chains is absolutely essential for producing biologically active
glycohormones like leutenizing hormones (Thotakura and Blithe, 1995).
Different cell types probably follow a specific program for glycosylation. The
differences in the glycosylation patterns within cell types is apparent considering the
various types o f glycosyltransferases and the cell surface carbohydrates expressed by these
cells. For example, the Chinese hamster ovary cell line that is often used to obtain
recombinant proteins predominantly expresses high mannose type oligosaccharides on its
cell surface. Therefore the proteins being transfected in this cell line often also end up
expressing high mannose type oligosaccharide structures. Thus if the expression of
specific type(s) of oligosaccharide(s) is required, it is very likely that the recombinant
protein would not exhibit the correct biological activity unless it was transfected in the right
cell type. A similar situation may be occurring with human recombinant ZP3. Human ZP3
is expressed by the egg cells and therefore may probably have to be expressed in a very
specific cell line to obtain biologically active recombinant human ZP3. The inability to
obtain a biologically active recombinant ZP3 molecule indirectly suggests that its
oligosaccharides may be playing an important role in mediating sperm receptor function.
Using the Hemizona Assay to Determine the Role o f Oligosaccharides in Human SpermZP Binding
The inability to directly assess the role of the ZP3 oligosaccharides in mediating
human sperm-ZP binding due to reasons specified above have therefore forced
investigators to search for other alternative strategies to study this interaction at the
molecular level. However, even for such indirect methods, the main challenge has been the
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availability of human eggs in significant numbers. Furthermore, incubation of live human
eggs with sperm could potentially result in the formation of human embryos, thus leading to
severe ethical dilemmas. To circumvent these problems, the hemizona assay was developed
(Burkman et al., 1988). The initial use of the hemizona assay was restricted to assessing
sperm dysfunction in male patients (Burkman, Coddington et al., 1988). The general
paradigm for conducting this assay is provided in Figure 5. In the first step, human eggs are
microbisected in to two equal halves. The halves are aspirated vigorously to expel the
cellular egg contents, leaving behind the two equal halves of the ZP known as hemizona. Of
these two hemizonae, one is used as a control and the other as the test (Figure 5). In the
clinical application, the control hemizona is incubated with sperm from normal known
fertile donor whereas the test hemizona is exposed to sperm obtained from the patient. The
incubation is carried out for 4 hours in an 5% CO2 incubator. The individual hemizona are
then washed thoroughly in media to remove any loosely bound sperm. The sperm that are
tightly bound to each hemizona are counted. Comparison of the number of sperm bound to
the test versus the control hemizona is done to assess the dysfunction of the sperm from the
patient. The comparison is done by calculating the hemizona index (HZI) as followsHZI= (Number of sperm Bound to the test Hemizona)/(Number of sperm bound to control
hemizona) X 100.
An HZI of 100 indicates no difference in the binding capacity of the sperm from the
patient. Complete sperm dysfunction is reflected if the HZI is 0.
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Figure 5: Schematic diagram of the modified hemizona assay (HZA) to test the effect of
different substances on human sperm-ZP binding. The human eggs are initially bisected
and the zona pellucida is isolated from the ooplasm. The test hemizona is incubated with
the sperm in the presence of the test substance and the control is incubated with sperm in
the presence o f PBS (or any other suitable placebo substance). The number of sperm
bound to the hemizona after 4 h incubation are counted and the hemizona index (HZI) is
calculated as shown.
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The main advantage of the HZA is that it provides an internally controlled test as
the matched hemizonae are derived by microbisection of the same egg (Burkman,
Coddington et al., 1988). The use of the same egg as the control and test also is beneficial
in reducing the number o f eggs required to do such studies. Considering these advantages,
the HZA was modified to perform various studies to assess the role o f different chemical
and biochemical agents to affect human sperm-ZP binding (Oehninger et al., 1990). The
test hemizona was incubated with sperm from healthy proven fertile donor (defined as a
donor who has fathered a child in the past two years), in the presence o f the test substance
and the control hemizona was incubated with the sperm from the same donor in the
absence of the test substance (Figure 5). The HZI is calculated by counting the number of
sperm bound to the test versus the control. The HZI indicates if the test substance had any
effect on human sperm-ZP binding as discussed above. The inhibitory effect of the test
substance in the HZI is calculated by the formula-% inhibition in the HZA = (100 - HZI).
A number of different substances were initially screened in the HZA for their effect
on sperm-ZP binding (Oehninger, et al., 1990). It was hypothesized that the test substance
that could potently inhibit sperm binding in the HZA would at least be mimicking the
natural ligands expressed on the surface of the zona. The identification o f such a substance
could therefore provide valuable insights about the molecular mechanisms involved in
mediating this adhesive event.
Fucoidcm, a Potent Inhibitor o f Sperm Binding in the HZA
Studies on mouse sperm-ZP binding had already indicated that the oligosaccharide
chains attached to the ZP could be playing an important role in this event. Therefore,
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initially Oehninger and co-workers, tested different glycoconjugates for their ability to
inhibit in the HZA (Mahony, et al., 1991; Oehninger, et al., 1991). Of all the
glycoconjugates tested at that time, fucoidan, an algal polysaccharide primarily composed
o f Fuc and sulfate, was found to be an extremely potent inhibitor of human sperm-ZP
binding in the HZA (Mahony, et al., 1991). Incubation of the test hemizona with the sperm
in the presence of 50 |ig/ml of fucoidan resulted in 80% inhibition of binding as compared
to the matched control. Other sulfated polysaccharides like dextran sulfate, chondroitin
sulfate did not have any effect on this interaction in the HZA (Oehninger, et al., 1991).
Furthermore it was found that neither Fuc nor sodium sulfate had any major effect on the
binding (Oehninger, et al., 1991). These control experiments therefore indicated that
fucoidan was specifically able to block sperm-ZP binding in the HZA.
Previously, Huang et al., (1982) had reported that fucoidan could block sperm-ZP
binding in humans. They also reported that fucoidan was also a potent inhibitor of spermZP binding in other mammalian species (Huang and Yanagimachi, 1984). For example
fucoidan could block the sperm binding in the mouse and the guinea pig system. However,
the action of fucoidan in these lower mammalian species was significantly different than
that observed in humans. In the lower mammals when sperm binding assays were
conducted in the presence of fucoidan, the sperm could undergo initial tight binding to the
ZP but would then eventually fall off (Huang and Yanagimachi, 1984). In humans however,
short term incubation (0.25-0.5 h) of fucoidan potently inhibited the initial binding
interaction (Huang et al., 1982; Clark and Oehninger, unpublished observations). Thus in
the lower mammalian species, fucoidan inhibited the secondary binding interaction whereas,
in humans the initial or primary binding was inhibited by this algal polysaccharide.
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Reevaluation o f the Structure o f Fucoidan
Other than demonstrating that an algal polysaccharide like fucoidan could inhibit human
sperm-ZP binding, these studies also indicated that similar to the mouse system, specific
glycoconjugates could be playing a major role in mediating human sperm-ZP binding. To
understand the molecular basis of the inhibition of fucoidan we undertook a study to
characterize the structure of this polysaccharide. The structure of fucoidan was first studied
in the 1950’s using the technology available at that time (Percival, 1967) (Figure 6). With
the availability of modem structural analysis tools like gas chromatography-mass
spectroscopy (GC-MS), a more sensitive and critical analysis o f the structure was
performed (Patankar, Oehninger et al., 1993). Our analysis indicated that contrary to the
findings of the early studies, the structure of fucoidan showed substantial differences when
analyzed by GC-MS. Previous studies performed by Percival et al (1967) indicated that
fucoidan was primarily a polymer of a 1-2 linked Fuc with relatively small number of
branches of Fuc extending from the core in a l-4 linkages (Figure 6). A majority of the
sulfates were shown to be present on the 4- position hydroxyl group. Our studies indicated
that the core structure of fucoidan is composed of a 1-3-linked Fuc chain that is highly
branched with a 1-2 and a l-4 fiicose units attached to the a 1-3 linked core structure
(Patankar, et al., 1993). This work constituted the major analysis completed for the
fulfillment of the Masters thesis of this candidate. Comparison between the previous and
the new model obtained for fucoidan are shown in Figure 6.
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Figure 6: The new average structure of fucoidan. Panel A and B show the previously
reported structure of this polysaccharide (Percival et al., 1967). The new average structure
reported for fucoidan is shown in Panel C.
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Fucoidan also Inhibits Selectin Mediated Events
In addition to its ability to block mammalian sperm-ZP binding fucoidan was also
shown to be a very potent inhibitor of L-selectin mediated attachment of the leukocytes to
the inflamed endothelium (Foxall et al., 1992). As mentioned earlier, sulfo-Lewisx and
sulfo-Lewis* terminated glycans are potent ligands for the selectins (Varki, 1994; (Yuen, et
al., 1992; Green, et al., 1992). Sulfo-Lewisx carries a a 1-3 linked Fuc and the sulfo-Lewisa
structure has a a 1-4 linked Fuc attached to a GlcNAc residue. Our data indicated the
presence of al-3 and a l- 4 branches of Fuc in fucoidan (Patankar, et al., 1993). The
concentration dependence of fucoidan’s inhibition of selectin mediated processes and of
sperm-ZP binding in the HZA was very similar (Foxall, et al., 1992). We therefore
hypothesized that fucoidan may be inhibiting both these processes by similar molecular
mechanisms (Patankar, et al., 1993). The natural extension of this hypothesis was that
human sperm-ZP binding could also involve a selectin-like binding process. This
observation indicated that a considerable overlap probably existed between the
carbohydrate ligands responsible for mediating human sperm-ZP binding and the
recruitment of leukocytes to the inflamed endothelium. We therefore proposed that initial
human sperm-ZP binding could be a selectin-like event (Patankar, et al., 1993). However
more proof was needed to support this hypothesis. In the first portion o f this study we
provide more evidence supporting an overlap of the carbohydrate ligands in the gamete
binding and the immune system. Our analysis suggests that the known selectin ligands
inhibit human sperm-ZP binding in the HZA.
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Direct Evidence Demonstrating the Role o f Carbohydrates in Human Sperm-ZP Binding
Saling and co-workers recently suggested that a 95 kDa tyrosine kinase activity,
ZRK, expressed on human sperm was the primary receptor responsible for mediating
gamete binding (Burks, et al., 1995; McLeskey, et al., 1998). Two peptide sequences
derived from the extracellular domain of ZRK were shown to inhibit human sperm-ZP
binding. An analysis of the primary protein sequence of ZRK did not indicate the presence
o f a carbohydrate binding domain. Therefore the results obtained with ZRK did not support
earlier evidence suggesting a role for carbohydrates in mediating initial human gamete
binding. A review of the literature did not reveal any conclusive studies that could counter
the suggestions made by Saling and co-workers (Burks, et al., 1995; McLeskey, et al.,
1998). We therefore focused our attention on obtaining direct evidence for the involvement
of carbohydrates in initial human sperm-ZP binding. Specific chemical and enzymatic
manipulations of the ZP oligosaccharide chains conducted in this study clearly indicate the
importance of the glycan chains in mediating human gamete binding.
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MATERIALS AND METHODS

All of the chemicals utilized in this study were analytical grade and were obtained
from Sigma Chemical Company, U.S.A unless otherwise indicated. Plates used for tissue
culture were obtained from Falcon, U.S.A Prior consent from the Internal Review Board
was obtained for collection of the human gametes. Eggs were obtained from donors
undergoing in vitro fertilization at the Jones Institute for Reproductive Medicine. Eggs
were stored in high salt solutions prior to use (Franken et al., 1989). Sperm samples were
obtained from healthy donors who had fathered a child in the past two years.
Isolation o f Hemizona
Flame drawn micropipets were utilized for micromanipulation o f the eggs and the
hemizonae. Salt stored eggs were rinsed in HAMS-F10 media containing 0.5% human
serum albumin (HAMS-HSA). The eggs were then bisected by a microsurgical cutting
blade which was manipulated using a Narishige micromanipulator on an inverted phase
contrast microscope (Nikon, Japan). The bisected eggs were aspirated vigorously in
HAMS-HSA to remove the ooplasmic contents. Both the hemizona were transferred to a
50 p.1 droplet of salt storage solution and stored at 4°C until used. To prevent evaporation
the droplets were stored under mineral oil.
Isolation o f Human Sperm
Human sperm were isolated from semen using the swim-up procedure. After
liquefaction, semen was pipeted into a 15 ml conical centrifuge tube. To this was added 5
ml of HAMS-HSA that had been aseptically prepared and stored overnight at 37°C in a 5%
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C 0 2 incubator. The diluted semen sample was centrifuged in a table top centrifuge at 400
X g for 7 min. The supemant was discarded and the precipitate was resuspended in 2 ml of
HAMS-HSA. The sample was centrifuged again at 400 X g for 5 min as before. The
supernatant was discarded. To the pellet, which was highly enriched in the sperm, was
carefully added 1 ml of HAMS-HSA. The tube was capped loosely and kept at an angle of
45° in the 5% C 0 2 incubator set at 37°C for 1 h. The swim-up sperm were then carefully
pipeted and placed in a 5 ml round bottom capped plastic sample tube. The concentration
and the motility parameters of the swim-up sperm were analyzed by using a HamiltonThome Motion Analyzer, specially programmed to analyze human sperm motion
parameters according to the World Health Organization (WHO) guidelines. Only sperm
samples that exhibited progressive motility above 70% were used.
Hemizona Assay
Hemizona assay (HZA) was performed as described previously (Burkman, et al.,
1988). Matched hemizona were always used in the assay. Salt stored hemizonae were
washed thoroughly by aspiration in HAMS-HSA. The control hemizona was then
transferred to 25-50 pi droplets of swim-up sperm (0.7 million sperm/ml media) and kept
under mineral oil to prevent evaporation. The test hemizona were transferred into identical
droplets containing sperm (0.7 million sperm/ml media) from the same donor premixed
with the known amount of the test substance. The control and the test droplets were stored
under mineral oil to prevent evaporation. The incubation o f sperm and hemizona was
carried for 4 h in a 37°C 5% C 0 2 incubator as previously described (Burkman, et al.,
1988). Prior to the assay the sperm were incubated for 4 h with the test substances to
check for any toxic effects and were assayed for motility as mentioned before. None of the
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substances tested in the HZA in this study significantly affected the motion parameters of
the sperm. When analyzed by the Hamilton-Thome sperm motion analyzer, the progressive
motility of the sperm in the presence of the test substances was > 75%.
After incubation for 4 hr, the control and test hemizonae were individually pipeted
out and placed in 100 pi HAMS-HSA droplets. Each hemizona was then washed 15 times
in separate HAMS-HSA droplets. The washed control and test hemizonae were placed in a
50 pi HAMS-HSA droplet and the sperm bound to each were visually counted. To control
for the quality of the hemizona, only the points where at least 20 sperm bound to the
control hemizona were considered. For statistical accuracy, each assay was performed at
least nine times. The effect of the test substance on sperm-ZP binding in the HZA was
measured by calculating the HZI.
Periodate Oxidation o f Hemizona
Oxidation of the oligosaccharides expressed on the ZP was performed by treating
the hemizona with sodium /w-periodate (SMP). For selective oxidation o f the terminal
NeuAc, the test hemizona were placed in a 50 pi ice cold droplet of phosphate buffered
saline (PBS; 20 mM sodium phosphate pH 7.4 containing 150 mM sodium chloride)
containing 1 mM SMP. The control hemizona were placed in 50 pi droplets of PBS
containing 1 mM SMP and 100 mM ethylene glycol. Ethylene glycol was added to stop the
SMP reaction. The droplets were covered with mineral oil to prevent evaporation and were
kept on ice for 10 min. After incubation, the test hemizonae were promptly drawn out of
the droplets and rinsed thoroughly by aspiration in PBS. The control hemizonae were also
similarly rinsed with PBS. The test and the control hemizona were then separately placed

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

42

under mineral oil in 50 pi droplets of PBS containing 100 mM sodium borohydride. This
step was performed to reduce any aldehydes that may have formed during the oxidation
with SMP on the hemizona. The reduction with sodium borohydride was performed for 1 h
at room temperature. Following reduction, the control and the test hemizonae were washed
thoroughly by aspiration in PBS and stored in salt storage solution until used in the
hemizona assay.
A similar procedure was used for the oxidation of the terminal sugars except that 10
mM concentration of SMP was used. The test hemizona were placed in a 50 pi droplet of
10 mM SMP in PBS. The oxidation was performed for I hr at room temperature. The
control hemizona were treated under identical conditions except that the incubation was
done in the presence of ethylene glycol (100 mM). After treatment with SMP, the test and
the control hemizonae were subjected to sodium borohydride reduction as described
previously. The test and control hemizonae were stored in salt storage solution until used in
the HZA.
Chemical Desialylation o f Human ai-Acid Glycoprotein
The NeuAc residues present on oligosaccharides expressed on human oti-acid
glycoportein (AGP) were removed by acid hydrolysis as described previously (Varki and
Diaz, 1984). AGP (10 mg) was dissolved in 2 ml 2 M acetic acid and heated at 80°C for 2
hr. The acid was neutralized with pyridine. The reaction mixture was then concentrated to
250 pi in an Amicon 10 kDa cutoff Centricon™ cartridge. The concentrated protein was
resuspended in 2 ml of PBS and was again concentrated to 100 pi. This step was repeated
at least 5 times to completely exchange the pyridine acetate present in the reaction mixture.
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Total protein retained was determined by assaying for absorbance at 280 nm which
indicated a 70% recovery. A stock solution of 7 mg protein in 140 pi PBS was prepared
for use in the hemizona assay.
Neuraminidase and Endo-fi-Galactosidase EBGase Treatment ofZP
Hemizona were obtained by microbisection o f human eggs as described before. The
hemizonae were washed thoroughly with PBS. Test hemizonae were placed in a 50 pi
droplet of PBS containing 1 unit/ml Clostridium perfringens type X neuraminidase
(Sigma). The control hemizona were placed in a 50 pi PBS droplet containing heat
inactivated Clostridium perfringens type X neuraminidase under otherwise identical
conditions. The droplets were covered with mineral oil to avoid any evaporation o f the
buffer and were incubated overnight at 37°C in a 5% CO2 incubator. After incubation the
control and test hemizona were individually washed in PBS and stored in salt storage
solution until further use in the HZA.
The conditions employed for EBGase treatment of the hemizonae was identical to
the one used for neuraminidase digestion, except that 4 unit/ml of EBGase enzyme (V
Labs) was used.
Staining o f Hemizonae with FITC-MAA
FITC-MAA lectin was used to determine the effect of chemical and enzymatic
treatments on the test and the control hemizonae. Test and the control hemizonae were
separately incubated for 15 min at room temperature in the dark in a 25 pi droplet o f PBS
containing either 5 or 10 pg/ml of FITC-MAA. The hemizonae were immediately removed
and washed thoroughly in PBS. The washed hemizonae were placed on a slide under a
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drop of Antiquench solution. Lectin binding to the hemizona was detected under a
fluorescent scope (Nikon Microphot FX equipped with a 627 nm bandpass filter). The
stained hemizona were photographed using the on-stage camera (FX-35WA). To make a
quantitative estimate of the amount o f FITC-MAA bound to the hemizona, the fluorescent
microscope was set on an auto exposure mode and the amount of time of exposure
estimated by the camera in order to get a clear picture was noted. An arbitrary scale for the
amount of fluorescent staining of the hemizona was set as follows- (+++-I-) 1-5 sec; (+++)
6-10 sec; (++) 11-20 sec; (+) 21-30 sec; (+/-) 31-40 sec; and (-) >40 sec.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

45

RESULTS

Sialyl Lewis' Inhibits Human Sperm-ZP Binding in the HZA
The structure of fucoidan resembled that o f sialyl Lewisx, the known selectin ligand.
We therefore decided that sialyl Lewisx was a good candidate to be tested in the HZA for
its effect on sperm-ZP binding. Incubation of the test hemizona with 1 mg/ml (10 mM) of
sialyl Lewisx resulted in approximately 60% inhibition (HZI = 36 ± 14 [standard error])of
sperm binding as compared to the matched control (Figure 7) (Clark et al., 1995). Human
ai-acid glycoprotein (AGP), an acute phase glycoprotein derived from plasma glycoprotein
and known to express minor amounts of sialyl Lewisx on its W-linked oligosaccharides also
inhibited sperm-ZP binding in the HZA. Approximately 50% inhibition (HZI = 46 + 22) of
sperm binding was observed when the test hemizona was incubated with 1 mg/ml of AGP
whereas 5 mg/ml of this glycoprotein resulted in 99.3% inhibition ( HZI = 1) in the HZA
(Clark, et al., 1995). Desialylated AGP obtained by chemical hydrolysis of the terminal
NeuAc did not exhibit significant inhibition of sperm-ZP binding when assayed at a
concentration of 1 mg/ml (HZI = 102 + 24) as shown in Figure 7. Desialylated AGP when
tested at 5 mg/ml resulted in about 80% inhibition (HZI = 22 ± 10) (Clark, et al., 1995).
However, at 5 mg/ml concentration of both the sialylated or desialylated AGP it is very
likely that non-specific effects may ensue resulting in strong inhibition of sperm binding in
the HZA.
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Figure 7: Inhibition o f human sperm-ZP binding in the HZA by sialyl Lewis* and AGP.
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Glycodelin-A
Dr. Oehninger in collaboration with Dr. Markku Seppala o f the University of
Helsinki, Finland, observed that placental protein 14 (PPM, previously also known as
progesterone associated endometrial protein, PAEP) was the most potent inhibitor of
human sperm-ZP binding in the HZA compared to other substances tested thus far
(Oehninger et al., 1995). PPM is a glycoprotein that is temporally expressed in the uterus
during pregnancy (Julkunen et al., 1985; Wahlstrom et al., 1985; Julkunen et al., 1986).
This glycoprotein is abundantly found in the amniotic fluid from where it is isolated by
using immunoaffinity chromatography (Julkunen, et al., 1985).
Contrary to previous reports, PPM is synthesized by the secretory and decidualized
endometrium and not by the placenta (Julkunen et al., 1986; Julkunen et al., 1988).
Expression o f this glycoprotein is also not regulated by progesterone. Therefore, the names
PPM and PAEP given to this glycoprotein were misnomers. In addition, PPM was also
found to be expressed in the seminal plasma and by the hematopoietic cells of the bone
marrow (Julkunen et al., 1984; Kamarainen et al., 1994). The results that will be discussed
below, clearly suggest a significant biological role for the glycans expressed on PPM
obtained from the amniotic fluid. Therefore to avoid confusion about the nomenclature of
the different forms of PPM we have renamed PPM or PAEP as Glycodelin (Gd) (Dell et
al., 1995). PPM obtained from amniotic fluid is now referred to as glycodelin-A (Gd-A)
whereas the seminal plasma isoform is now named as glycodelin-S (Gd-S). Similarly the
new name given for the hematopoietic isoform of PPM is glycodelin-H (Gd-H) (Dell, et al.,
1995). This nomenclature will be followed throughout the remaining portions of this thesis.
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Structural Characterization o f Gd-A Oligosaccharides
In addition to its ability to block sperm-ZP binding in the HZA, Gd-A was also
shown to be an extremely potent suppressor of specific immune responses (Bolton et al.,
1987; Pockley et al., 1988; Pockley et al., 1989; Pockley and Bolton, 1989; Pockley and
Bolton, 1990; Okamoto et al., 1991). Our studies with fucoidan, sialyl Lewisx and AAG
strongly suggested that the oligosaccharide ligands involved in mediating human sperm-ZP
binding closely mimicked the sugars recognized during specific immune responses.
Therefore, we thought it likely that the contraceptive and immunosuppressive properties of
Gd-A could be manifested by the glycans expressed on this glycoprotein. We undertook a
study to characterize the structure of the Gd-A oligosaccharides.
The characterization of the Gd-A oligosaccharides was performed in collaboration
with Drs. Anne Dell and Howard Morris from Imperial College, (London) and Dr. Markku
Seppala. Fast atom bombardment-mass spectroscopy (FAB-MS) and electron spray-mass
spectroscopy (ES-MS), two extremely sensitive tools for carbohydrate and peptide analysis
were used for this analysis. The structural characterization studies were mainly done by the
group at Imperial College and therefore only the main results of this collaborative study are
discussed here as they provide valuable information absolutely essential for the conclusions
of this present study. Therefore, the exact methodologies used for the structural
characterization of the glycosylation sites and the oligosaccharides of Gd-A are also not
described in detail here. A succinct flow chart of the various methodologies used is
however included (Figure 8 ). For more information the reader is directed to the original
manuscript (Dell, et al., 1995).
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Figure 8 : Schematic diagram of the strategies utilized for the structural characterization o f
the glycodelin glycans and for mapping o f their glycosylation sites. For mapping o f the
glycosylation sites, the glycodelins were either treated with trypsin and analyzed by FABMS or treated with cyanogen bromide. Cyanogen bromide results in cleaving the peptide
sequence at the methionine residues. The cleaved peptides obtained were analyzed by LCES-MS. For structural characterization o f the glycans, the proteins were treated with
trypsin and the glycopeptides were isolated. FAB-MS profiles of the total glycan mixture
were determined. In other experiments, the glycodelin glycans were released from the
glycopeptides by the enzyme PNGase F. The free oligosaccharides were further analyzed
using three different strategies. (1) The free glycans were subjected to sequential
exoglycosidase digestions and the FAB-MS profiles recorded after each round of enzyme
treatment. (2) For linkage analysis, the glycans were methylated and then hydrolyzed. The
free hydroxyl groups of the released methylated monosaccharides were acetylated and
analyzed by GC-MS. (3) To determine the fiicosyl linkages, the free glycans were
permethylated and then subjected to mild methanolysis to remove the Fuc residues. The
free hydroxyl groups were remethylated and the glycans analyzed by FAB-MS. The data
obtained from all of these strategies was collectively used to determine the structures of
the glycodelin glycans.
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The primary protein sequence o f Gd-A carries three consensus sites for Ar-Iinked
glycosylation. The glycosylation sites in Gd-A were determined by mapping the tryptic GdA glycopeptides by FAB-MS or by microbore liquid chromatography-electron spray-mass
spectroscopy (LC-ES-MS) of the glycopeptides obtained after treatment with cyanogen
bromide. FAB-MS and LC-ES-MS data indicated that only two of the sites, Asn 28 and
Asn 63 were glycosylated. No 0-linked sugars were detected on this glycoprotein.
Analysis of the TV-linked oligosaccharides was performed using FAB-MS techniques
coupled with specific glycosidase digestions as described previously by Dell and coworkers (Dell, 1987). The glycans expressed on Gd-A were either biantennary or
triantennary. FAB-MS analysis of these glycans indicated the presence of highly unusual
oligosaccharide chains on this glycoprotein (Figure 9). A vast majority of the TV-linked
glycans found to be expressed on various mammalian glycoproteins carry the Gal014GlcNAc sequence on their non-reducing terminals (Figure 2 ). This sequence is referred to
as the lacNAc sequence. However, approximately 50% of the Gd-A glycans expressed
GaINAc0 l-4GlcNAc (lacdiNAc sequence) at their terminal ends in addition to the
commonly observed lacNAc glycans (Figure 9). The expression of the lacdiNAc sequence
in humans is highly restricted. It has been shown to be expressed on various pituitary
glycohormones and also on recombinant human protein C expressed in the human kidney
293 cell line (Grinnell et al., 1991; Grinnell et al., 1994). The terminal lacdiNAc glycans
present in Gd-A were further modified by NeuAc and Fuc. Approximately 60% o f the
glycans were sialylated and 20% were fucosylated (Dell, et al., 1995). All of the NeuAc
was attached to the terminal Gal or GalNAc via a a2-6 linkage. The Fuc was attached to
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Figure 9: Structures of the oligosaccharides present in Gd-A_ The panel on the left shows
the different glycans present on Asn 28 whereas the panel on right shows all of the glycans
present on Asn 63. Open circles-Man, closed circles-Gal, open ellipse-NeuAc, open
inverted triangle-Fuc, open squares-GIcNAc, and closed squares-GalNAc.
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the penultimate GlcNAc in a al-3 linkage. The al-3 fucosylation and sialylation of the
same antenna were found to be mutually exclusive events. A significant number (30%) of
the binantennary glycans carried both the lacNAc and lacdiNAc antennae within a single
structure.
Structural Characterization o f Gd-S Oligosaccharides
As mentioned above, a seminal plasma isoform of Gd-A is also present. Since Gd-A
exhibited potent contraceptive activities, it was initially puzzling why a potentially
contraceptive glycoprotein could also be expressed in the seminal plasma as it could
severely affect the sperm-ZP binding. It was considered very likely that Gd-S may not be
expressing the unusual glycans expressed on Gd-A and could therefore not be
contraceptive. Initial studies conducted in Dr. Seppala’s laboratory indicated major
differences in the lectin binding profiles of both Gd-A and Gd-S. Wisteria floribunda
agglutinin (WFA) is a lectin that selectively binds the GalNAc (Koistinen et al., 1996). In
an ELISA-type assay, WFA was found to bind strongly to Gd-A. However, Gd-S did not
bind WFA (Koistinen, et al., 1996). Similarly, Gd-S did not bind Sambucus nigra
agglutinin (SNA) a lectin that binds to ot2-6 linked sialic acids (Koistinen, et al., 1996).
These two observations indicated the absence of lacdiNAc and the a.2-6 linked sialic acid
sequences in Gd-S. Gd-S was however found to avidly bind to Lotus tetragonolobus lectin,
a lectin that binds to a l-3 and al-2 linked Fuc (Koistinen, et al., 1996). The lectin binding
studies therefore indicated major differences in the structures of Gd-A and Gd-S glycans.
To conclusively determine the differences in the glycan structures o f Gd-A and GdS, the oligosaccharides attached to Gd-S were characterized by using ES-MS and FAB-MS
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(Morris et al., 1996). The strategies adopted for the characterization were similar to the
methodologies utilized for the characterization o f Gd-A glycans (Morris, et al., 1996)
(Figure 8 ).
FAB-MS and LC-ES-MS analysis confirmed the differences in the Gd-S and Gd-A
glycans observed by the lectin binding studies. As in the case of Gd-A, Gd-S also carried
two TV-linked glycosylation sites but no O-linked oligosaccharides. Asparagine (Asn) 28
and asparagine (Asn) 63 were both glycosylated as in the case of Gd-A. The first
glycosylation site (Asn 28) carried only high mannose type glycans (Figure 10). All of the
glycans present on Asn 63 were biantennary complex type oligosaccharides (Figure 10).
However, none o f these biantennary glycans were of the unusual lacdiNAc type but were
instead composed of the commonly occurring lacNAc sequences. Contrary to the Gd-A
glycans which were highly sialylated, the Gd-S oligosaccharides were not sialylated. More
than 80% of the glycans on asparagine 63 carried between 3 and 5 fucose residues per
glycan. A substantial percentage of the glycans were terminated with the Lewis* (Gaipi4[Fucal-3]GlcNAc-) and the Lewisy ([Fucal-2]Galpl-4[Fucod-3]GlcNAc-) sequence.
The Lewisy sequence was totally absent in Gd-A.
Gd-S Does Not Inhibit in the HZA
FAB-MS analysis clearly indicated major differences in the structures of the Gd-S
and Gd-A glycans. It was therefore reasoned that if the contraceptive activities exhibited by
Gd-A in the HZA were mediated by its glycans, then Gd-S may exhibit differential activities
in this gamete binding assay. To test this hypothesis, a comparative study of the effect of
Gd-A and Gd-S in the HZA was performed at 1, 10 and 25 fig/ml concentration o f the two
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Figure 10: Glycans expressed on Gd-S. The structures shown in the left panel are the
glycans found on Asn-28 and the ones on the right are the glycans expressed on Asn-63.
Open circles-Man, closed circles-GaL, open ellipse-NeuAc, open inverted triangle-Fuc, and
open squares-GlcNAc.
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glycodelins (Morris, et al., 1996) (Figure 11). Gd-A at 25 ng/ml inhibited sperm-ZP
binding in the HZA by 90% (HZI = 6 .6). At the same concentration Gd-S did not produce
any effect on the number of sperm binding to the ZP (HZI = 93.3 ± 20). Similarly at 1 and
10 pg/ml concentration of Gd-A approximately 30% (HZI = 70 + 33) and 70% inhibition
(HZI = 33.3 ± 10) of sperm-ZP binding was observed respectively. At these
concentrations, Gd-S did not inhibit but instead was found to slightly increase the number
of sperm binding to the ZP (Figure 11).
Oxidation o f Terminal Sugars with SklP
SMP selectively oxidizes molecules carrying vicinal (adjacent) hydroxyl groups.
Sugars carry hydroxyl groups on vicinal carbon atoms which can be oxidized by SMP
(Figure 12). Under mild conditions (10 mM SMP at room temperature for 1 h) selective
oxidation of cell surface associated oligosaccharides can be achieved (Van Lenten and
Ashwell, 1971; Kalyan et al., 1982;Vacquier and Moy, 1977). Oxidation o f these vicinal
hydroxyl groups results in the cleavage of the furanose or pyranose ring structure of the
sugars and the formation of aldehydes on both sides o f the oxidation site. The sites for
SMP oxidation o f galactose and the products obtained in this reaction are shown in Figure
13.
Many cell surface associated oligosaccharide chains are terminated with a NeuAc
residue. NeuAc does not carry any vicinal hydroxyl groups within its ring structure.
However, vicinal hydroxyl groups are present on the glycerol side chain attached to the C6
carbon of NeuAc. Very mild oxidation conditions (1-2 mM SMP, at 0-5°C for 10 min) are
sufficient to attack this glycerol chain of the NeuAc residues (Figure 14). Previous studies
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indicate that under very mild conditions, the vicinal hydroxyl groups present on the C7-C8
positions o f NeuAc are predominantly attacked resulting in the formation of a six carbon
sugar referred to as heptulosonic acid (Figure 14). The internal sugars present in the
oligosaccharide chain are not affected by this chemical treatment. Reactive aldehydes are
generated after SMP oxidation reaction. Such reactive aldehydes can form imine linkages
(>C=NH), also known as Schiffs base, with primary amine groups present in proteins.
Such secondary reactions may pose problems when bioassays are being performed. The
reactive aldehydes can however be converted to the less reactive alcohols by reduction with
sodium boro hydride (100 mM at room temperature for 1 h) permitting the use of SMP
oxidation to assess the role of the oligosaccharides in a bioassay. Therefore to assess the
requirement for the human ZP oligosaccharide chains in mediating sperm-ZP binding, the
hemizonae were treated with SMP, reduced with sodium borohydride and assessed for their
ability to bind sperm using a standard HZA protocol.
Very M ild SMP Oxidation
Very mild SMP oxidation was performed to oxidize the terminal NeuAc residues.
To control for any side effects that SMP or any possible impurities may have on the
hemizonae, the control hemizonae were also treated under identical conditions with the
same concentration of SMP. However, a 100-fold molar excess of ethylene glycol (100
mM) was added to inactivate the periodate, thereby blocking oxidation of the ZP
oligosaccharides. The test and the control hemizonae were then subjected to treatment with
sodium borohydride.
The effect of very mild oxidation on hemizona was apparent when the test and the

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

63

control hemizonae were assayed for their ability to bind to MAA, a lectin that specifically
binds cx2-3 linked sialic acids (Figure 15). Lectin binding studies performed in our
laboratory and those reported by others had indicated significant binding of FITC-MAA to
the human ZP. The test hemizonae obtained after very mild SMP oxidation showed
significantly less binding to FITC-MAA as compared to the controls (Figure 15). When
tested for sperm-ZP binding in the HZA, approximately 30% inhibition was observed in the
case of the test hemizona as compared to their matched controls (Table 4). This result
clearly indicated that specific oxidation of the sialic acids expressed on the human ZP
affected their ability to bind sperm.
M ild SMP Oxidation ofZP Oligosaccharides
Test hemizonae were treated under mild oxidation conditions with SMP (10 mM, 1
hr at room temperature), to oxidize vicinal hydroxyl groups on both the ring and straight
chains. The controls were treated under identical conditions except that 1 M ethylene
glycol was added to inhibit the oxidation. Test and control hemizonae were subjected to
sodium borohydride treatment. The HZA conducted with the test and the control under
standard assay conditions indicated approximately 40% inhibition of sperm binding to the
test hemizona (Table 4).
Enzymatic Treatment ofZP With Neuraminidase andEBGase Increases Sperm Binding
SMP oxidation of the ZP under mild and very mild conditions resulted in a
significant decrease in sperm binding in the HZA indicating a role for the terminal sugar
residues in mediating this interaction. We therefore decided to test the effect of enzymatic
removal of some of terminal sugars of the ZP on sperm binding in the HZA Two enzymes

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 15: Reduced binding of FITC-MAA to the SMP treated hemizona. Panel A is a
control hemizona. Panel B is a matched test hemizona that was treated under mild SMP
oxidation conditions. The control and the test zona were incubated with FITC-MAA,
washed and visualized under a fluorescent microscope.
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Table 4: Effect of chemical and enzymatic treatments on human sperm-ZP binding in the
HZA.

# o f Sperm

# o f Sperm

Number o f

Bound to

Bound to

Eggs used

Control

Test

in Study

61 ± 1 0

73 ±23

26 ±4

22

<0.01

70 ±11

42 ±16

36 ± 11

24

<0.05

Neuraminidase

297 ±45

60 ± 10

150 ± 22

22

<0.001

EBGase

710 ±232

28 ± 10

104 ±25

14

<0.001

20.7 ± 4.4

76 ± 10

12 ± 3

16

<0.001

Treatment

Mild SMP

HZI

/7-value

Oxidation
Very Mild SMP
Oxidation

Neuraminidase
+ Mild SMP
Oxidation
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used in this study were neuraminidase and EBGase. Neuraminidase is a exoglycosidase that
specifically cleaves NeuAc from the terminal ends of the oligosaccharides. In this study,
neuraminidase (Type X, Sigma) obtained from Clostridium perfringens was used. This
neuraminidase is known to be a highly purified preparation and is not found to contain any
significant activities of other glycosidases or proteases. The Clostridium perfringens
enzyme cleaves sialic acids in ot2-3 linkage with high affinity, although it also hydrolyses
the a2-6 linked NeuAc at a slower rate.
We had previously observed that treatment of the ZP with this neuraminidase (1
unit/ml) for 1 h did not significantly affect sperm-ZP binding in the HZA (Clark, et al.,
1995). However, NeuAc residues in mammals have been shown to carry glycolyl or acetyl
groups. In some cases, a2-8 linked NeuAc has also been reported. It was therefore likely
that if ct2-8 linked NeuAc or a chemically modified NeuAc residues were expressed on the
human ZP, the Clostridium perfringens neuraminidase would either be unable to desialylate
the oligosaccharides or could cleave the NeuAc at a very slow rate. Human ZP were
therefore treated with the Clostridium perfringens neuraminidase for 8 h before analyzing
the effects of desialylation in the HZA. The extent of desialylation was determined by the
binding of FITC-MAA to the test hemizonae. Results similar to the one shown in Figure 15
were obtained when the neuraminidase treated hemizona were labeled with FITC-MAA.
Test hemizona were treated with the neuraminidase and the control hemizona were treated
with heat inactivated neuraminidase.
Desialylated hemizona when assayed for sperm binding under standard HZA
conditions gave an unexpected result (Table 4 ). Although oxidation of terminal NeuAc of
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the ZP oligosaccharides resulted in a decrease in sperm binding, enzymatic removal of this
sugar caused a 2.5-fold increase in sperm binding to the test hemizona as compared to the
matched controls which were treated with heat inactivated enzyme.
Previous studies have clearly indicated the presence of lactosaminoglycan sequences
on murine and porcine ZP (Hokke, et al., 1994; Nagdas, et al., 1994). Therefore human
hemizona were digested with a specific enzyme that degrades lactosaminoglycans
(EBGase) by cleaving internal pi-4-linked Gal residues within these repeating co-polymers
(Fukuda, et al., 1984). Digestion of the test hemizona with EBGase also resulted in
approximately 4-7 fold increase in the number of sperm binding (Table 4).
SMP Oxidation o f Neuraminidase Treated ZP Inhibits Sperm Binding
The increase in sperm binding observed after treatment o f the ZP with
neuraminidase and EBGase could be explained by the fact that the egg binding protein on
the sperm recognize an internal oligosaccharide sequence. Therefore enzymatic removal of
the outer NeuAc residues or polylactosamine type chains resulted in better binding of this
egg binding protein to its ligands. In previous experiments with fucoidan it was observed
that SMP was unable to oxidize the Fuc branches. It was thought that the high degree of
sulfation present in fucoidan inhibited the chemical action of SMP, possibly due to the
electrostatic effects (Clark and Patankar, unpublished results). A similar problem could
possibly exist in the case of digestion of the ZP with SMP, where the high degree of
sialylation of the ZP could result in inhibition of the SMP and so the internal sequences that
were recognized by the egg binding receptor were not completely oxidized. In addition,
SMP oxidation does not completely remove terminal sugar residues. For example, SMP
oxidation results in the modification of the terminal NeuAc to heptulosonic acid, which
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remains attached to the oligosaccharide chain of the ZP (Figure 14 ). Such modified
glycans could perturb the presentation of the ZP glycans and may therefore not be
recognized by the egg binding protein of the sperm. Therefore incomplete oxidation or the
presence of chemically modified terminal sugars could result in only a 40% inhibition of
sperm binding to the mildly oxidized hemizona rather than a complete abrogation (Table 4).
To address this possibility, the test and the control hemizona were treated with
neuraminidase as explained in the previous experiment. The neuraminidase treated
hemizona were then subjected to mild SMP oxidation as mentioned before (10 mM SMP at
room temperature for 1 h). These manipulations resulted in a 80% inhibition of sperm
binding to the test hemizona as compared to the control (Table 4). Therefore removal of
sialic acid followed by periodate oxidation resulted in substantial inhibition of binding.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

70

DISCUSSION

Specific Inhibition o f Sperm-ZP Binding by Sialyl Lewis*
Based on the structural and biological properties of the algal polysaccharide
fucoidan, we had suggested that initial human sperm-ZP binding may involve a selelctinlike interaction (Patankar, et al., 1993). The results obtained in this study provide further
evidence supporting this hypothesis. In previous studies it was observed that the Lewisx
(Galpl-4[Fucal-3]GlcNAc),

Lewisb

or

Lewis*

(Gal pl-3[Fucal-4] GlcNAc)

oligosaccharides were unable to block sperm binding in the HZA (Clark and Oehninger
unpublished results). It was also observed that fetuin, a bovine glycoprotein expressing Nlinked glycans similar to AGP but lacking the sialyl Lewisx epitope exhibited no inhibitory
effect when assayed in the HZA (Clark and Oehninger unpublished observations). In this
context the significant inhibition of sperm-ZP binding by sialyl Lewisx and AGP in the HZA
is likely a specific effect (Figure 7). We have also demonstrated that desialylation of AGP
renders it ineffective in inhibiting in the HZA (Figure 7). It is therefore very likely that the
sialyl Lewisx oligosaccharide mimics the actual oligosaccharides expressed on the human
ZP that are required to mediate the gamete interaction.
Relatively high concentration of sialyl Lewisx or AGP was required to obtain any
significant inhibition of sperm binding in the HZA. However, it has been reported that sialyl
Lewisx also inhibits selectin mediated adhesions in the same concentration range required in
this study to inhibit human gamete binding (Varki, 1994). None of the carbohydrate ligands
identified so far are capable of binding to the selectins with sufficient adhesive strength
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required to counter the extremely high shear forces that are experienced by the leukocytes
(Varki, 1994). One possible reason that has been presented for this discrepancy is that the
key to producing a very high affinity interaction lies in the manner in which the
oligosaccharide ligands are being presented on the proteins or lipids. It has been suggested
that these ligands when presented in patches or clusters serve as more effective ligands
(Varki, 1994). Recognition o f these clusters by the selectins results in a very high avidity
interaction, leading to the binding of leukocytes to the endothelium even in the presence of
high shear forces. Therefore, although sialyl Lewisx is the correct ligand for the selectins, its
presentation in a monovalent fashion rather than a polyvalent manner results in low affinity
interaction requiring considerably higher concentration of this oligosaccharide to block Eselectin mediated events in in vitro assays.
It is likely that a similar situation exists with the human sperm-ZP binding in the
HZA. In the present study sialyl Lewisx was tested as a monovalent ligand. We have made
several attempts to couple multiple molecules of different oligosaccharides to carrier
proteins or to other polymeric supports. However, the presence of multiple hydroxyl
groups on the sugar molecules poses a major problem in achieving specific labeling of the
oligosaccharide chain. The reducing end (a hemiacetal) of the oligosaccharide is the only
position that can possibly be used for tagging the molecule with chemical linkers, enabling
polyvalent attachment of the sugars to carrier proteins or polymeric supports. The most
convenient method of tagging the reducing end of the sugars is to react it with linker arms
bearing primary or secondary amines leading to the formation of imines which could
eventually be reduced to amines using sodium cyanoborohydride, a reaction sequence
commonly known as reductive animation. We have synthesized various biotinylated
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reagents that carry 8-12 carbon atom linker arms with primary amine groups at their
terminal ends. Our intention was to biotinylate the oligosaccharides o f interest with these
reagents which could allow us to present the sugars in a tetravalent manner when coupled
with avidin, a protein known to bind up to four moles of biotin. A similar strategy was used
by Rothenberg and co-workers (Rothenberg et al., 1993) for biotinylation of
oligosaccharides. However, our studies indicate that although efficient coupling of monoand disaccharides can be achieved, coupling o f higher oligosaccharides with these reagents
results in extremely low yields (data not shown). We have therefore been unable to test
sialyl Lewis’1presented in a polyvalent fashion in the HZA.
In addition to polyvalent presentation, sialyl Lewis* may have to be presented in the
context of an N-linked glycan on a protein platform. This possibility can be supported by
the inhibition shown by AGP. Only 20-24% o f the total glycans expressed on AGP carry
the sialyl Lewis* epitope (Walz et al., 1990). As mentioned above, fetuin has no effect on
sperm-ZP binding in the HZA. The only major difference in the glycans expressed on fetuin
and AGP is the presence of sialyl Lewis* epitopes on the latter. Assuming that the protein
structure of AGP does not play a role in the inhibition of sperm binding in the HZA (an
assumption clearly supported by studies performed with desialylated AGP), it is clear that
only 6% of the total glycoforms of AGP must be producing the inhibitory effect. Thus a 1
mg/ml concentration of AGP which produces 50% inhibition in the HZA actually
corresponds to only 200-240 jig/ml concentration of the AGP glycoform that bears the
sialyl Lewis* epitope on its glycan chain. It is therefore possible that the sialyl Lewis*
bearing AGP glycoform if isolated selectively could lead to a much more potent inhibition
o f sperm-ZP binding in the HZA In this context it can therefore be argued that precise
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presentation of the appropriate oligosaccharide iigand(s) may be the key to obtaining very
effective inhibition of the gamete binding process at low concentrations.
Specific inhibition o f human sperm-ZP binding in the HZA by fucoidan, sialyl
Lewisx oligosaccharide and AGP suggested that these glycoconjugates may be mimicking
the structure of the actual ligand expressed on the ZP and thereby preventing its interaction
with the egg binding protein expressed on the surface of the sperm. Our data indicate that
sialyl Lewisx oligosaccharide inhibited both human sperm-ZP binding and E-selectin
mediated adhesion over the same concentration range. These observations gave further
support to our hypothesis that human sperm-ZP binding may involve a selectin-like event.
More evidence in favor of this hypothesis was gained from the oligosaccharide structural
analysis and the HZA inhibition profiles of the glycodelins.
Gd-A Glycans Inhibit Sperm-ZP Binding
Antibody binding studies performed by Seppala and co-workers indicated that all of
the monoclonal antibodies produced against Gd-A also recognized Gd-S in Western blot
analysis and also in dot blot assays (Seppala and Koistinen, personal communications).
Sequencing data of 22 amino acids from the AT-terminal of Gd-A and Gd-S was exactly
identical (Seppala and Koistinen, personal communications). LC-ES-MS analysis further
indicated that fragmentation pattern of the peptides obtained from both the glycodelins was
identical. All of this evidence therefore strongly indicates that the primary amino acid
sequence of both Gd-A and Gd-S is identical. It is therefore very likely that the tertiary
structure of both the glycodelins is also similar. Indeed both Gd-A and Gd-S exhibit similar
electrophoretic mobilities when analyzed by non-denaturing or denaturing polyacrylamide
gel electrophoresis (PAGE). Both the glycodelins have also been shown to form dimers in
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solution. Thus for all practical purposes it must be assumed that Gd-A and Gd-S are
different glycoforms of the same protein synthesized by different tissues.
Inhibition studies performed in the HZA clearly indicate that while Gd-A is a potent
inhibitor of sperm-ZP binding, Gd-S has no effect on this interaction (Figure 11).
Therefore, considering the similarities between the protein structures of these two
glycodelins it must be concluded that the differences in the biological properties exhibited
by these glycoproteins are due to the expression of their significantly different W-linked
glycans (Figure 9, 10). The glycodelins therefore provide additional proof that only specific
glycoconjugates are capable of blocking initial attachment of the human gametes. The
current goal in our laboratory is to synthesize the unusual glycans expressed on Gd-A to
test their effect in the HZA. It is likely that these glycans could serve as efficient inhibitors
of the gamete binding process and could therefore be used effectively for further research
purposes (e.g. identification of the egg binding receptor present on human sperm) or could
also be used to devise novel contraceptive agents. As will be discussed in Chapter IV of
this thesis we have developed a new technique for the synthesis of glycopeptides. Using
this method we have been able to efficiently synthesize the fucosylated lacdiNAc type
biantennary glycopeptides and confirm their structures by FAB-MS analysis. We are
currently collaborating with Dr. Thomas Plummer (Division of Molecular Medicine, New
York State Department, NY) in order to synthesize all of the different Gd-A glycans and
test their efficacy to block sperm-ZP binding in the HZA. It should however be noted that
as in the case o f sialyl Lewis*, the proper presentation may be an absolute requirement for
the Gd-A glycans to exhibit inhibitory activities in the HZA
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Human Sperm-ZP Binding as a Selectin-Like Event
Previous studies indicated that decidual extracts containing Gd-A were capable of
suppressing thymidine uptake in both normal and mitogen-stimulated human mixed
lymphocyte cultures (Bolton, et al., 1987). However selective removal of Gd-A from these
extracts using anti-Gd-A antibodies resulted in a loss of these inhibitory responses. Gd-A
was also shown to decrease the synthesis of interleukin-1 (IL-1) and interleukin-2 (IL-2),
two cytokines that play a prominent role in initiation and maintenance of cytotoxic immune
responses (Pockley, et al., 1989; Pockley and Bolton, 1989; Pockley and Bolton, 1990).
Furthermore, this glycoprotein also inhibited the synthesis of IL-2 receptors by mitogenstimulated cells (Pockley, et al., 1988). Additionally, Okamoto and co-workers had shown
that Gd-A suppressed killing of the erythroleukemia cell line K562 by human natural killer
(NK) cells in an in vitro assay (Okamoto, et al., 1991). The K562 cells have been
conventionally known to be extremely good targets for the human NK cells. Based on the
significant contraceptive and immunosuppressive effects exhibited by Gd-A coupled with
our observations with fucoidan and sialyl Lewis', we hypothesized that the oligosaccharide
chains expressed on Gd-A could also be responsible for mediating its potent
immunosuppressive activities.
The highly unusual fiicosylated lacdiNAc type glycans have been previously shown
to be expressed on human recombinant protein C by Yan and co-workers (Grinnell, et al.,
1994). This group of researchers have also shown that the fucosylated lacdiNAc sequence
is a 15-20 fold more potent inhibitor of E-selectin binding to human umbilical vein
endothelial cells (an experimental system used extensively to study the E-selectin) than
sialyl Lewis' (Grinnell, et al., 1994). Our structural analysis of the Gd-A glycans therefore
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indicated that very potent selectin ligands are expressed on this glycoprotein (Figure 9).
The presence of selectin ligands on Gd-A and its potent contraceptive and
immunosuppressive activities therefore added support to our hypothesis that human spermZP binding may involve a selectin-like interaction.
Initial Human Sperm-ZP Binding- A Carbohydrate Mediated Event
Extensive studies performed by many investigators have clearly indicated the
involvement o f the ZP oligosaccharides in mediating gamete binding in the mouse
(Wassarman, 1990). However, unambiguous evidence required for proving a similar role
for the ZP glycans in human sperm-ZP binding had not been obtained. Studies performed
by Saling and co-workers have suggested that a 95 kDa zona receptor kinase (ZRK)
expressed on the human spermatozoa is the actual egg binding protein (Leyton and Saling,
1989; Burks et al., 1995). Since all of the known protein tyrosine kinases can only bind to
different peptides, the presence of ZRK has clearly instilled doubt about the role of the ZP
oligosaccharides in mediating human gamete interaction (Aitken, 1995). Experiments
performed with fucoidan have clearly indicated that specific glycoconjugates were capable
of inhibiting sperm binding to the ZP (Mahony, et al., 1991). The present study was
therefore undertaken to help resolve this controversy. The results obtained in our studies
clearly indicate a role for the oligosaccharides in mediating human sperm-ZP binding.
The effect of chemical and enzymatic treatments on the ZP performed in this study
provide strong evidence for the role o f carbohydrates in mediating human sperm-ZP
binding. They also illuminate the molecular events that may be occurring during this initial
gamete interaction. Desialylation or EBGase treatment of the ZP results in a 2.5-3 fold
increase in the number of sperm being bound to the ZP (Table 4). At least two reasons
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were postulated to explain this substantial increase in sperm binding to the neuraminidase
or EBGase treated ZP.
(1) It was theorized that the ligand for the egg binding protein present on the sperm is
actually a peptide or protein epitope present on the ZP which is exposed due to the
enzymatic removal of some of the terminal sugars;
(2) The egg binding protein o f human sperm recognizes internal carbohydrate
structures that are exposed due to the treatment of neuraminidase and EBGase.
Results obtained in this study, however, do not support the requirement of a
protein-protein interaction for mediating initial human gamete binding. Studies with
fucoidan, sialyl Lewis* AGP and the glycodelins clearly indicate that specific sugars can
inhibit sperm-ZP binding. Furthermore, selective oxidation of the terminal sugars results in
significant inhibition of sperm binding in the HZA. However, possibly the best data
indicating the requirement of protein-carbohydrate interaction for mediating human spermZP binding was obtained from the final experiment performed in this study. Mild oxidation
of desialylated ZP inhibited sperm binding by 80% (Table 4). This result suggests that a
majority (80%) of the sperm binding sites exposed after neuraminidase digestion are
sensitive to mild periodate oxidation
The results of SMP treatment and neuraminidase digestion indicate that there may
exist two modes for human sperm-ZP binding. The first mode depends in part upon the
binding of terminal sialic acid. The second mode is independent of this terminal sugar.
Binding in the presence of terminal sialic acid is weaker, either because o f lower affinity or
decreased numbers of binding sites of this type.
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In this context it is interesting to note that Testart and co-workers have reported
that desialylation of human sperm by Arthrobacter ureafaciens neuraminidase also leads to
3-fold increase in their ability to bind to the human ZP (Lassalle and Testart, 1994). Recent
evidence indicates the presence of a 54 kDa sialic acid binding protein in the human uterine
secretions (Baneijee and Chowdhury, 1997). This sialic acid binding protein has been
shown to bind to a 23 kDa sperm plasma membrane protein (Baneijee and Chowdhury,
1997). The interaction o f these two proteins results in the desialylation o f the human sperm,
possibly by the activation of a sperm surface associated neuraminidase. Thus desialylation
o f either the spermatozoa or the ZP may lead to a substantial increase in sperm-ZP binding.
The results obtained in this study combined with those reported by other
investigators suggest a new carbohydrate dependent model for initial human gamete
interaction. When the gametes encounter each other, the sperm plasma membrane
associated neuraminidase interacts first with the sialylated oligosaccharides of the ZP,
providing sufficient affinity for initial weak attachment of the spermatozoa. The
neuraminidase activity then cleaves the ZP associated sialic acid enabling access of the
other lectin-like egg binding proteins of the sperm to bind strongly to the glycan sequences
located beneath this terminal sugar. This process may be facilitated by oviductin, a
glycoprotein that binds to the ZP in the oviduct and greatly enhances this interaction
(O’Day-Bowman et al., 1996). Thus the transition between loose sperm attachment and
subsequent tight primary binding of the human gametes could be explained by this ‘active
digestion’ model combined with other glycoproteins that promote adhesion.
There is some indirect evidence that supports this model. Optimal sperm binding to
the ZP requires an extended incubation of 4 h (Burkman et al., 1988). The HZA when
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applied as it is in our studies is considered to be a measure of tight binding (Burkman et al.,
1988) that leads to the induction of the acrosome reaction (Franken, et al., 1991). Such an
extended period of incubation of the hemizona with the spermatozoa may be required to
enable the desialylation of the ZP glycans by the sperm associated neuraminidase activity
resulting in the exposure of the internal oligosaccharide chains. The tight binding of the
sperm to the hemizona in the HZA may hampered due to the lack of the adhesion
facilitating glycoproteins like oviductin that are present in vivo.
The results obtained with EBGase are also significant. Litscher and Wassarman
(1996) isolated a restricted 55 kDa lactosaminoglycan-containing glycopeptide from mouse
ZP3 glycoprotein that blocked murine sperm-ZP binding. Digestion of this glycopeptide
with EBGase resulted in a substantial loss o f glycan mass but did not affect its capacity to
inhibit gamete interaction. By contrast, the results of our EBGase digestion studies indicate
that lactosaminoglycan type chains block potential binding sites for human spermatozoa.
These rather bulky extensions of glycans obscure the binding sites either directly by being
attached to the potential binding glycans or indirectly by being in close proximity to them.
Conclusion
The data obtained by studying the specific inhibition o f sperm-ZP binding by
glycoconjugates and by specific chemical and enzymatic manipulation of the ZP clearly
indicates that the oligosaccharides expressed on the ZP are absolutely responsible for
mediating initial human gamete binding. Considerable work will be needed to determine
exactly how human spermatozoa bind to the ZP. However, the evidence indicates that this
interaction may be considerably more complex than previously thought. The involvement of
sialic acid, the evidence for a sperm-associated neuraminidase, and other considerations

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

80

discussed here support this conclusion.
Data obtained from experiments using sialyl Lewisx, AGP, and the glycodelins have
provided further proof that this initial interaction between the gametes may involve a
selectin-like interaction. On-going research initiatives undertaken in our laboratory will
focus on the characterization of the exact molecular events taking place during the initial
human gamete interaction. The current study has raised the possibility of the requirement of
a sperm surface neuraminidase in mediating this process. Further proof will be needed to
prove this requirement.
Utilizing the latest technological advances in oligosaccharide structural analysis
coupled with the experiments performed in the HZA, it is very likely that substantial
information can be obtained about the initial human gamete binding events. Our future
goals will be oriented to reach this objective.
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CHAPTER III
INTRODUCTION

In our studies with the sperm-ZP binding system we observed that only those
glycoconjugates that bear close resemblance to the selectin ligands are capable of inhibiting
initial gamete interaction (Clark, et al., 1995). Fucoidan, sialyl Lewisx and the fucosylated
lacdiNAc terminals present on some of the Gd-A glycans have all been shown to be potent
ligands for the selectins (Foxall, et al., 1992; Grinnell, et al., 1994; Varki, 1994). These
studies suggest that the carbohydrate binding specificities of receptors mediating gamete
recognition and lymphocyte/leukocyte adhesion may overlap at least to a certain extent.
However, monoclonal antibodies directed against selectins do not bind to human
spermatozoa, suggesting the existence of distinct egg binding proteins on the human
spermatozoa that can bind to the selectin ligands. Why would it be beneficial for
carbohydrate-dependent recognition systems to overlap in the human? What type of
selective advantage(s) would be gained under such circumstances? A review of the
literature in human reproduction and glycobiology strongly suggests that such a
convergence could facilitate the exchange of information necessary to protect the human
embryo/fetus during its development. The studies that lead us to this conclusion are
discussed below. However, some of the essential aspects of human reproductive
immunobiology are reviewed first.
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The Ultimate Parasite
The human embryo formed after fertilization of the egg undergoes repeated cell
divisions ultimately resulting in the formation of the blastocyst (Edwards, 1994). The
blastocyst produces specialized cells known as the syncytiotrophoblasts. These cells invade
and extravasate into the basement membrane of the uterine wall resulting in successful
implantation of the embryo. Due to movement of the embryonic cells into the maternal
endothelium the implantation is invasive resulting in close interactions between the
embryonic cells like the trophoblasts and different components of the maternal immune
system. Some of these embryonic cells express both the maternal and paternal antigens like
the major histocompatibility complex (MHC) (Loke and King, 1991; Schmidt and Orr,
1993). The paternal antigens are usually foreign to the mother’s immune system. The
embryo is therefore usually referred to as a “semi-allograft”. In some cases of surrogate
pregnancy, the embryo is a complete allograft. The expression of foreign antigens on the
embryonic cells should therefore evoke a strong maternal immune response against the
implanting embryo (Loke and King, 1991; Wegmann and Guilbert, 1992; Schmidt and Orr,
1993). Evidence suggests that factors capable of producing a strong immune response are
present throughout the period of pregnancy (Loke and King, 1991). The placenta expresses
MHC class I antigens and some pregnant women also carry anti-HLA antibodies developed
against the paternal antigens that theoretically should interfere with subsequent pregnancies
with the same male (Regan et al., 1991). However, these women are usually capable of
carrying the fetus to fiill term.
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Human decidua of early pregnancy contains considerable numbers o f natural killer
(NK) cells (Loke and King, 1991). The NK cells are capable of killing cells that do not
express the self MHC molecules. However, in most cases the presence of such factors that
would normally launch allograft rejection of foreign tissues does not lead to fetal rejection.
The fetus generally survives through the whole period of pregnancy. This situation is
analogous to persistent infection with some parasites. Such parasites are capable of
surviving immune challenge in the human hosts. These parasites are also adapted to obtain
nutrients, and oxygen preferentially, characteristics shared by the fetus. It is for this reason
that the embryo/fetus is sometimes referred to as the ultimate parasite.
It is generally accepted that specific suppressive factors are produced during the
period of pregnancy inducing the immunotolerance that allows the fetal allograft to survive
during its intrauterine development.

Since pregnant women are not generally

immunocompromised during or after pregnancy, it has been hypothesized that this
immunosuppressive effect is highly localized to the uterus and expressed only during
pregnancy (Hegde, 1991). Various factors like progesterone, a-fetoprotein, human
chorionic gonadotrophin and the non-polymorphic MHC antigens such as HLA-G
expressed on trophoblast at the fetomatemal interface have been implicated in maintaining
this localized immunosuppressive effect (Hegde, 1991).
The Human Embryonic Defense System Hypothesis
Our recent findings and several other glycobiological observations suggest that
specific glycoconjugates expressed by the endometrium in conjunction with those produced
by the human embryo/fetus are responsible for manifesting significant contraceptive, anti
inflammatory, and immunosuppressive effects. This system is based upon specific
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glycoconjugate interactions that abrogate initial sperm-egg binding, block selectin-mediated
adhesions, and suppress lymphocyte-mediated responses. All of these activities expressed in
a specific temporal fashion may serve to protect the developing embryo/fetus. We therefore
refer to this model as the human feto-embryonic defense system hypothesis or the HuFEDS hypothesis (Clark, 1996). Known components of this system originate or are present
in the glandular epithelium of the endometrium, the embryo/fetus, human amniotic fluid,
and the human placenta.
The Different Components o f the Hu-FEDS
Human amniotic fluid contains mucins of fetal or endometrial origin that inhibit Eselectin mediated adhesions (Walz et al., 1990). The mucins probably mediate this effect via
their covalently linked sialyl Lewisx terminated oligosaccharides. These mucins could
therefore block acute inflammatory responses during pregnancy by inhibiting the primary
adhesion o f inflammatory cells. However, recruitment and activation of lymphocytes and
other immune cells may require receptors other than the selectins. It is therefore likely that
these mucins may not play a major role in potently inhibiting the lymphocyte-mediated
responses.
Furthermore, the immune cell type that is found in the uterus during pregnancy is
the CD3‘CD56+ natural killer (NK) cells (Sato et al., 1990). However, these decidual cells
do not attack the fetus under normal circumstances and have greatly reduced cytotoxicity.
It is therefore likely that other components are expressed in the uterus during pregnancy
that are specifically responsible for abrogating such lymphocyte responses.
We believe that Gd-A is one of the major component of this glycoconjugate based
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immunosuppressive system. The expression of Gd-A is temporally and spatially regulated.
During the menstrual cycle, Gd-A is not expressed in the proliferative endometrium but
increases significantly from the fourth postovulatory day, peaking around day 12 (Julkunen,
et al., 1986). Thus Gd-A expression is at a minimum during the peri-ovulatory period of the
cycle. However, at the time of implantation of the embryo, Gd-A synthesis in the decidua is
induced to very high levels (4-10% of total protein). This glycoprotein is also found in
significant concentrations in the amniotic fluid, reaching a final concentration above 40
pg/ml by mid-trimester.
As mentioned in the discussion section o f Chapter n, Gd-A manifests several
suppressive activities when tested in the immunological assay systems. Gd-A has been
shown to be involved in inhibiting the thymidine uptake in stimulated lymphocytes,
suppression of the cytokines IL-1, IL-2 and IL-2 receptor synthesis, and to block the lysis
of K562 cells by the NK cells at low concentrations (Bolton, et al., 1987; Pockley, et al.,
1988; Pockley, et al., 1989; Pockley and Bolton, 1989; Pockley and Bolton, 1990;
Okamoto, et al., 1991). Thus previous reports clearly suggest that Gd-A manifests potent
immunosuppressive effects. Gd-A synthesis is highly localized. Although it is found in the
blood of pregnant women, its maximal systemic concentration (2 (ig/ml) is well below that
required for the suppression of the T- and NK cell responses (Julkunen, et al., 1985). The
highly regulated temporal and spatial expression and the potent immunosuppressive effects
manifested by Gd-A clearly meet all of the necessary criteria that would be necessary for an
agent responsible for mediating immunotolerance of the embryo/fetus during pregnancy.
a-Fetoprotein (AFP) a glycoprotein that is synthesized by the fetal liver and the
yolk sac has been associated with mediating immunosuppression of the fetal and the
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maternal immune responses (Deutsch, 1991). Suppression o f the fetal immune response
during pregnancy is also likely to be crucial for maintaining tolerance of the developing
human. AFP is also synthesized by hepatomas and other ovarian cancer cells and is
therefore referred to as an oncofetal antigen (Ruoslahti, 1979). Previous studies indicate
that AFP expressed during early pregnancy carries bisecting type TV-linked glycans (Figure
16). The expression of the bisecting type glycans on AFP peaks around week 16 of
pregnancy and then slowly declines so that at the time of birth no bisecting GlcNAc
sequence is present on this glycoprotein (Deutsch, 1991).
Recent studies indicate that glycans bearing the bisecting GlcNAc sequences
(Figure 16) suppress NK cell response when expressed on the cell surface. Electroinsertion
of glycophorin, a major erythrocyte glycoprotein, into membranes of K562 cells makes
them resistant to NK cell attack (el Ouagari et al., 1995). K562 are human erythroleukemic
cells which do not express any MHC Class I molecules and are therefore efficiently killed
by human NK cells. Glycophorin expresses one //-linked glycan in addition to many other
CMinked chains (el Ouagari et al., 1995). A substantial number of the TV-linked glycans of
glycophorin are of the bisecting type. Selective removal of these TV-linked glycans
associated with glycophorin by the enzyme PNGase F completely eliminates its ability to
suppress NK cell mediated responses. In addition stable transfection of K562 cells with the
enzyme that catalyzes the synthesis of the bisecting GlcNAc sequence (GlcNAc transferase
HI; Table 2) yields NK cell resistant transformants that show enhanced expression of this
glycan on their cell surface (Yoshimura et al., 1996).
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Figure 16: Structure of the bisecting type biantennary glycan associated with the
suppression of NK cell mediated cytotoxicity.
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The temporal expression of the bisecting type glycans on AFP during pregnancy
points to an interesting feature. It is possible that expressing different type o f glycans on the
same carrier protein like AFP at different time points during pregnancy permits an
additional control on the physiological events. Such dynamic changes in the glycosylation
patterns o f the same protein could possibly allow the same protein to perform different
biological function(s). Thus such temporal variations in the glycosylation patterns probably
makes the system extremely flexible to adapt to the ever changing physiological needs
during pregnancy.
A M odel For the Biological Actions o f Gd-A
As discussed in Chapter H, Gd-A is a potent inhibitor of human sperm-ZP binding
in the HZA. To our knowledge, this finding is the first demonstration that a human
glycoprotein can manifest both immunosuppressive and contraceptive effects. It is very
likely that the temporal regulation of Gd-A synthesis prevents this contraceptive
glycoprotein from interfering with the fertilization of the human eggs. As mentioned above,
Gd-A is not synthesized during the peri-ovulatory cycle, the period when fertilization
occurs. Subsequent induction of Gd-A synthesis 4-5 days after ovulation possibly creates a
contraceptive microenvironment in the uterine cavity. Thus a ‘fertilization window’ may
extend from the time of ovulation to the induction of endometrial Gd-A synthesis. Any
spermatozoa that migrate through the uterine cavity after the synthesis o f Gd-A has been
initiated would encounter this contraceptive glycoprotein in the uterine fluid and thus
would be unable to fertilize eggs released outside the appropriate temporal window.
A large number of NK cells are recruited to the uterus just after fertilization. Unlike
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the T- or B-cells, the NK cells do not require prior exposure to antigen to manifest
cytolytic activity against their targets. The pre-embryo is therefore a potentially vulnerable
target for the NK cell cytolytic responses. However, through these initial developmental
stages the pre-embryo is still encapsulated in the ZP. It is probably at this time that the
glycans expressed on the ZP provide a protective shield to successfully ward off any such
immune responses. At about the same time, Gd-A is being increasingly synthesized by the
decidual cells. Therefore, during the implantation process, when the embryo ‘hatches’ out
of its protective ZP shield, Gd-A provides efficient protection against the NK cells.
Implantation o f the embryo therefore continues, unabated by the maternal immune system.
It must be noted here that other glycoconjugates, as yet known or unknown, may also be
produced during this process which also play a role in immunoprotection. However, it is
true that Gd-A remains the best characterized immunosuppressive factor expressed during
pregnancy.
The Gd-A Glyccms
As mentioned in the discussion section of Chapter II, Gd-A carries highly unusual
fiicosyiated lacdiNAc type sequences. Such sequences have been previously shown to be
potent selectin ligands. It is intriguing to note that mature schistosomes and filarial worms,
two highly persistent parasites known to infect humans, also carry the fiicosyiated lacdiNAc
sequence (Srivatsan et al., 1992; Kang et al., 1993). It will be interesting to investigate if
these parasites utilize the same glycoconjugate based system of evading immune responses
that are used to protect the human embryo/fetus from the maternal immune response. If
these parasites do use a similar system for protecting themselves from the host’s immune
response, the term parasite used for the human embryo/fetus could take on a new meaning.
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It should be noted that tumor cells that express selectin ligands exhibit enhanced
tumorigenicity, suggesting that such glycans may also be protecting the cancer cells from
cell-mediated immune responses.
All of the NeuAc expressed on Gd-A is linked in the a2-6 configuration to the
terminal Gal or GalNAc. CD22, a B-cell maturation receptor has been shown to bind a2-6
linked NeuAc. Although we have not been able to demonstrate binding of Gd-A to CD22
by using affinity chromatography or Western blot analysis, it must be noted that a potential
role for the cc2-6 linked NeuAc does exist. We are currently synthesizing the different
glycans expressed on Gd-A to better characterize their roles in different immunological
assay systems. Such studies would provide considerable information that would be vital to
obtaining unambiguous evidence for the Hu-FEDS hypothesis.
Goals o f the Current Study
The specific expression of Gd-A during pregnancy, the occurrence o f highly
unusual but potent selectin ligands on this glycoprotein coupled with the expression of
these glycans on parasites like schistosomes and filarial worms strongly suggests that a
glycoconjugate based system protecting the developing human embryo/fetus exists.
Considerable evidence will no doubt be needed to prove the Ku-FEDS hypothesis. It would
also be extremely useful to determine if such a system of immunoprotection also exists in
other placenta-bearing mammals. If so, it could be possible to utilize lower mammals or
primates as models to study the existence of such a system. In the present study we have
attempted to determine the expression of immunosuppressive carbohydrates on the surface
of the human gametes. The rationale behind the current study is briefly summarized below.
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As mentioned previously, the glycans expressed on the ZP may also be playing a
role in protecting the developing pre-embryo. A similar situation exists with the sperm.
Insemination o f the female results in recruitment of large number of neutrophils (Pandya
and Cohen, 1985). Unless coated with anti-sperm antibodies, the neutrophils do not
phagocytose the spermatozoa (D’Cruz et al., 1992). In most cases, the neutrophils kill the
phagocytosed pathogens like bacterial and viruses by ingesting and then “bathing” them
with reactive oxygen species like peroxides. Antibody coated sperm somehow manage to
completely suppress the release of hydrogen peroxide and free radicals into the pahgosome
of the neutrophils after phagocytosis (D’Cruz, et al., 1992). Furthermore, in most cases,
the female immune system is recurrently exposed to the sperm antigens. However, usually
no major immune response is produced against the sperm antigens. In those cases where
anti-sperm antibodies are produced, the female usually experiences severe fertility
problems.
Human gametes do not express any MHC class I molecules on their surface. The
major immune cell type found in the uterus are the NK cells (70-80% of total immune and
inflammatory cells). NK cells survey both immune and non-immune cells of the body for
self Class I molecules and destroy those cells where such molecules are missing (Moretta et
al., 1992). The NK cells are therefore continuously surveying for targets that lack the
expression of MHC Class I molecules. The human gametes perfectly fit the profile for being
good candidates for destruction by NK cells. In addition to the human gametes, the cells
produced by the embryo, syncytiotrophoblasts, and the villous trophoblasts are all Class I
negative (Vince and Johnson, 1995). The extravillous cytotrophoblasts express HLA-G, a
restricted polymorphism MHC molecule known to suppress the NK-cell mediated
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cytotoxicity (Chumbley et al., 1994; Pazmany et ai., 1996). It is therefore very likely that
these embryonic cells and the human gametes engage a system independent o f MHC
recognition to protect themselves against lysis by the NK cells.
Based on our previous studies with Gd-A, we hypothesized that the human gametes
may also be evading immune recognition in the female reproductive tract by expressing
specific glycoconjugates. Our goal for this study was therefore to determine if any
immunosupressive glycans are expressed on the human ZP. The lack of sufficient numbers
of human eggs precluded our ability to directly analyze the ZP glycans. Therefore in this
study we attempt to probe the human ZP with specific lectins to determine if any o f the
glycans previously implicated in mediating immunosuppression are expressed on their
surfaces. In a previous study several lectins were tested for their ability to bind to human
ZP (Shalgi et al., 1991; Maymon et al., 1994). Three lectins that were not tested in this
previous study were analyzed in this study to determine if they could bind to human ZP.
These lectins were selected because they bind to glycan sequences associated with
glycoconjugates that suppress NK cell-mediated cytotoxicity. Sambuciis nigra agglutinin
(SNA) was chosen because o f its specificity for terminal cc2-6 NeuAc linked to a
lactosamine sequence (Gaipi-4GlcNAc) (Shibuya et al., 1987). As mentioned before, the
a2-6 linked NeuAc is expressed on Gd-A. Wisteria floribunda agglutinin (WFA), a
GalNAc binding lectin that is known to bind to the oligosaccharides carrying terminal
fiicosyiated lacdiNAc type sequences (Nyame et al., 1989) that were also found on Gd-A.
Both WFA and SNA have been shown to react with Gd-A in a carbohydrate dependent
manner. Erythroagglutinating phytohemaglutinin (E-PHA) the third lectin used in this study
has a very strict specificity for the biantennary and triantennary JV-linked glycans that bear a
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bisecting GlcNAc linked pi-4 to the P-linked mannose (Figure 17) (Cummings and
Komfeld, 1982; Yamashita et al., 1983). This molecular probe was chosen because the
bisecting type glycans recognized by this lectin have been shown to suppress NK cell
activity

when

they

are

expressed

on

cell

surfaces

as

discussed
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Figure 17: Oligosaccharide sequences recognized by E-PHA Ri and R2 are either a
hydrogen or a carbohydrate group.
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MATERIAL AND METHODS

Materials and Human Samples
Fluorescein isothiocyanate (FITC)-labeled E-PHA, SNA and WFA were purchased
from

E-Y

laboratories

(San

Mateo,

CA,

USA).

Conalbumin,

bovine

milk

galactosyltransferase, trypsin and uridine 5’-diphosphogalactose were purchased from
Sigma (St. Louis, MO, USA). Human gametes were obtained and manipulated as explained
in the materials and methods section of Chapter H.
Synthesis o f Inhibitors o f FITC-E-PHA Binding
Conalbumin was digested with trypsin after derivatization as previously described
(Dell, et al., 1995) to yield glycopeptides (3 mg) that were enzymatically galactosylated by
incubation

with

bovine milk P-galactosyltransferase

(5

units)

and

uridine-5’-

diphophogalactose (5 mg) for 24 h under optimal conditions (Barker, et al., 1972). A
sample of the glycopeptides (100 mg) was digested with peptide N-glycosidase F to yield
oligosaccharides that were analyzed by FAB-MS as previously described (Dell, et al.,
1995). This analysis confirmed complete galactosylation o f the conalbumin glycans to
biantennary and triantennary bisecting type N-Iinked oligosaccharides that would react with
E-PHA (Cummings and Komfeld, 1982; Yamashita, et al., 1983).
Lectin Binding Studies
The lectin binding to the human eggs and hemizona was performed as described in
the materials and methods section of Chapter H. The swim-up sperm obtained as described
in the methods and materials section o f Chapter II were used for labeling with FITC-E-
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PHA. Non-acrosome reacted swim-up sperm were air dried overnight on a glass slide,
methanol-fixed for 15 min and rehydrated in PBS as described previously (Cross and
Overstreet, 1987). The slide was incubated in PBS containing FITC-E-PHA for 15 min,
washed five times in PBS and inspected for fluorescence as described for the human egg
and hemizona.
Labeling o f sperm with FITC-E-PHA in Solution
Swim up sperm at a final concentration of 0.5 million cells/ml in HAMS-HSA were
incubated for 10 min at room temperature. The effect of the lectin on the sperm was
visually observed under a phase contrast microscope.
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RESULTS

No detectable binding of FITC-SNA or FITC-WFA to whole human eggs was
observed even when relatively high concentrations of the lectins (50 pg/ml) was used (data
not shown). Extremely strong binding of FITC-E-PHA to the whole human egg was
detected (Figure 18). This binding was detectable even at low lectin concentrations of 1
(ig/ml. Optimal binding was seen at 10 (ig/ml concentration of FITC-E-PHA Hemizona
obtained by microbisection of the eggs and removal of the cellular contents of the ooplasm
were also found to bind strongly to FITC-E-PHA. For the hemizona the binding was
observed even at 1 pg/ml concentration, however, optimal binding was observed at 5 pg/ml
concentration of the lectin (Figure 18). There was a universal homogeneous binding of
FITC-E-PHA to all eggs and hemizona tested. The binding of FITC-E-PHA was
carbohydrate specific. A mixture of biantennary and triantennary bisecting type N-linked
glycans obtained from conalbumin significantly reduced FITC-E-PHA binding to the
hemizona (Figure 18).
In a previous study it was shown that immobilized human spermatozoa also bind EPHA in a carbohydrate dependent manner (Cross and Overstreet, 1987). We were able to
reproduce this result. Substantial labeling of immobilized spermatozoa was observed when
incubated with 20 (ig/ml FITC-E-PHA (Figure 18). Labeling was found all over the
surface of the sperm, although the acrosomal region was found to be more highly labeled.
In other experiments we have also observed that live swim-up sperm bind to E-PHA in
solution. In solution E-PHA has been shown to form tetramers. The lectin can therefore
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Figure 18: Binding of FITC-E-PHA to human gametes. FITC-E-PHA strongly binds to
the whole human egg (Panel A). Panel B shows that the lectin binding to hemizona,
indicating that the E-PHA binding sites exist on the ZP. The binding of this lectin can be
considerable reduced by adding a bisecting type glycan bearing glycopeptides isolated and
synthesized from conalbumin (Panel C). Panel D shows binding of the lectin to sperm.
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bind four moles of the bisecting type //-linked glycans. We have observed that incubation
o f the live sperm with low amounts of E-PHA results in rapid agglutination o f the sperm.
When the sperm were incubated with 10 and 20 (ig/ml of the lectin at room temperature an
almost instant aggregation of the sperm was observed (data not shown). Incubation with 1
and 5 pg/ml required 5 min and 2 min respectively for the spermatozoa to aggregate (data
not shown).
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DISCUSSION

In the present study we were unable to show binding of WFA and SNA to the
human ZP. It is therefore unlikely that the fiicosyiated lacdiNAc or a2-6 linked NeuAc
would be expressed on the human ZP. As mentioned earlier these sugars were found on the
Gd-A glycans. We have however demonstrated that E-PHA binds strongly to the human
ZP (Figure 18). E-PHA has been previously shown to be highly specific for bisecting type
biantennary and triantennary iV-linked glycans.
As mentioned earlier, the human gametes do not express MHC class I antigens. The
expression of bisecting type N-linked glycans may therefore be crucial for the suppression
of NK cell-mediated responses especially after the egg is fertilized and the paternal
contribution to the embryonic genome becomes detectable. Spermatozoa may also
encounter NK cells during their movement through the uterus to reach and fertilize the egg.
How spermatozoa are protected from maternal NK cells is currently unknown. It is
however possible that the spermatozoa are also protected due to the presence of specific
oligosaccharide sequences like the bisecting type AMinked glycans.
Conclusion
Using specific lectin probes we have clearly demonstrated the presence of glycans
that may be involved in suppression o f NK cell mediated responses. The results obtained in
the next chapter clearly indicate that the bisecting type A-linked glycans can inhibit the NK
cell function. These results therefore strongly suggest that glycoconjugate dependent
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suppressive system, as outlined in the Hu-FEDS hypothesis, plays a major role in
protecting the human gametes and the developing embryo/fetus from the maternal immune
responses.
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CHAPTER IV
INTRODUCTION

Natural killer (NK) cells comprise approximately 5-10 % of the total lymphocyte
population in the human body. The NK cells are known to provide immune surveillance by
killing tumor and some virally infected cells that do not express self MHC molecules (See
et al., 1997). Their physiological role therefore complements that played by the Tlymphocytes in mediating cellular immunity in mammals. The T-cells specifically recognize
the foreign peptides presented on the self MHC molecules. Detection of such foreign
peptides results in cytolysis of the target cells. However, in some virally infected or tumor
cells the expression of MHC molecules on their surface is either lost or severely down
regulated. The NK cells have the ability to recognize the absence of self MHC molecules
and resulting in the killing of such targets. In essence, therefore the NK cells are involved in
the recognition of “missing self’. This hypothesis was first put forward by Karre (1991).
The major phenotypic difference between the T- and the NK cells is the lack of the
T-cell receptor (TCR) complex in the latter (Leiden et al., 1988). The T-cells are capable of
identifying the various foreign peptides due to the presence of TCR. Similar to the gene
recombination events that occur with the immunoglobulin molecules leading to the
formation of antibodies with different antigen specificities, gene rearrangements lead to the
various T-cell clones carrying TCR with different peptide specificities. A vast repertoire of
T-cell clones is therefore generated with each clone capable of identifying a specific foreign
peptide sequence when presented on the MHC molecules of the antigen presenting cells.
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The mechanism for target recognition utilized by the NK cells is however very
different. Similar to the T-cells, different clones of the NK cells have been reported. Each
o f these clones has a strict specificity to a particular MHC allele. For example based on
their specificity for the HLA-C alleles, the human NK cells have been classified as Group 1
and Group 2 clones (Moretta, et al., 1997). The group 1 clones recognize the Cw2, Cw4,
Cw5, and Cw6 alleles whereas the group 2 clones recognize the Cwl, Cw3, Cw7, and Cw8
alleles (Moretta, et al., 1997). Presence of these alleles on a normal cell inhibits their killing
by the respective clones. Such alleles are therefore termed as “protective alleles”. NK cell
clones specific for different alleles of the HLA-A and HLA-B molecules have also been
reported (Moretta, et al., 1997). The allelic specificities of the different NK cell clones has
been elucidated by transfecting HLA class I negative cells with the different HLA class I
alleles and the ability of such cells to evade NK cell cytolysis. Experiments performed with
HLA-C alleles have indicated the existence of a dimorphism in the amino acid residues at
positions 77 and 80 in the a i domain of the HLA-C molecules. The protective alleles
recognized by the Group 1 clones have a asparagine at position 77 and lysine at position
80. Alleles that inhibit lysis mediated by the Group 2 NK cell clones have a serine at
position 77 and asparagine at position 80 (Moretta, et al., 1997).
Recognition of the specific HLA class I alleles is mediated by different inhibitory
receptors expressed on the surface of the NK cells. Such receptors are expressed clonally
on the NK cells. One such inhibitory receptor is termed as p58, a 58 kDa protein (Moretta,
et al., 1997). Two different molecular forms of p58 have been identified to be characterized
on two different NK cell clones. The p58.1 inhibitory receptor has been found to recognize
Cw4 as the protective HLA-C allele whereas NK cells expressing p58.2 require the Cw3
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allele to suppress their cytolytic responses (Moretta, et al., 1997).
Other known NK cell inhibitory receptors are Ly49 in the mouse, and p70, or pl40
in the human. The intracytoplasmic tails o f all of these NK cell inhibitory receptors (also
known as killer cell inhibitory receptors, KIR) carry the immunoreceptor tyrosine-based
inhibitory motif (ITIM) which is used for cell signaling. Binding o f the receptor to its
specific HLA allele results in the activation of intracellular phosphatases like the SHP-1 in
the mouse resulting in a signaling cascade which leads to inhibition of the cytolytic
response (Mason et al., 1997). It is significant that truncated forms o f all o f these inhibitory
receptors lacking the ITIM motifs serve as activating receptors (also known as killer cell
activating receptors, KAR) (Ciccone et al., 1996). There appears to be a delicate balance
between the responses mediated by the activating and the inhibitory receptors that controls
the cytolytic activity of the NK cell against a target cell.
Suppression o f NK cell Responses by Glycoconjugates
In addition to the mechanisms discussed above, the cytolytic responses mediated by
NK cells have also been shown to be inhibited by various glycoconjugates. Gd-A potently
inhibits lysis of K562 erythroleukemic cells by NK cells (Okamoto, et al., 1991). The
bisecting type GlcNAc sequence (Figure 16) expressed on glycophorin has also been
suggested to block NK cell responses (el Ouagari, et al., 1995; Yoshimura, et al., 1996). It
is as yet very unclear how such glycoconjugates mediate their inhibitory effects. However,
many KIR like CD94, NKG2, and NKR-P1A in the human and NKR-P1 in the rat have
been shown to possess C-type lectin domains (Moretta, et al., 1997). Furthermore,
truncated forms of all of these lectin receptors that do not carry the ITIM motifs have been
shown to serve as KAR’s. The presence o f the C-type lectin domains on these receptors
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strongly suggests a role for glycoconjugates in mediating NK cell recognition. The role of
these lectin receptors is currently under intense scrutiny.
Focus o f the Current Study
In our previous study (Chapter IE) we have shown that the bisecting type //-linked
glycan is expressed on the human gametes. It is therefore likely that expression of this type
of glycan may be responsible for suppressing the anti-embryo/fetus responses that could be
mediated by the maternal NK cells that are recruited in high numbers during the
implantation process. However, concrete evidence for the involvement o f the bisecting type
//-linked glycan in suppressing the NK cell responses has not been clearly demonstrated. In
this study we have therefore attempted to determine the effect of the bisecting type glycans
on NK cell function. Inhibition of the NK cell cytolytic responses by such glycans could
provide valuable evidence for the existence of a glycoconjugate based suppressive system
responsible for protecting the human embryo/fetus from the maternal immune system as
outlined in the Hu-FEDS hypothesis.
It must however be mentioned at the outset that all of the studies shown here
should be considered with a restriction. Due to ethical considerations uterine NK cells
could not be obtained from pregnant women. Therefore all of the experiments were
conducted using peripheral blood NK cells. Uterine NK (CD2+, CD3', CD16+, CD56+,
0094") cells are of a different phenotype than those found in the peripheral blood (CD2+,
CD3', CD16+, CD56+/", CD94+/'). It is therefore possible that the effect of the glycans tested
on the peripheral blood NK cells may not be similar to that on the uterine NK cells.
Considering the constraint placed due to the unavailability of the correct biological
materials, we believe that the peripheral blood NK cells can serve as an excellent model.
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Ovomucoid A Source fo r Bisecting Type Glycans
In Chapter III we utilized the glycopeptides enzymatically synthesized and isolated
from conalbumin, a chicken egg albumin protein, as a source to obtain the bisecting type
glycans used to block the binding of FITC-E-PHA to the hemizona. However, conalbumin
was found to express very low level of the bisecting type biantennary glycan (5-10%) and
high levels of the bisecting type triantennary glycan that also reacts with E-PHA (Corradi
da Silva et al., 1994). As mentioned earlier, the bisecting type biantennary glycans
expressed on glycophorin were found to be essential for inhibiting NK cell function.
Conalbumin would therefore have yielded low amounts of the bisecting type biantennary
glycans. Ovomucoid is a 23 kDa glycoprotein that is present in significant amounts in the
chicken egg white. This glycoprotein has four major A-glycosylation sites (Asn-10, Asn-53,
Asn-75 and Asn-69) with one partial glycosylation site (Asn-175) (Yet et al., 1988). A
summary of the different carbohydrate chains expressed on the four major glycosylation
sites is shown in Figure 19. Table 5 lists the amount of each glycan present on the four
major glycosylation sites. A majority of the glycans expressed on ovomucoid are non
galactosylated (Figure 19). However small amounts of these glycans bear 1-2 moles of
galactose on each glycan chain (Table 5). The bisecting type biantennary glycan is present
in either the non- or partially galactosylated form on 26, 33, 36 and 40% of the glycans at
Asn-10, Asn-53, Asn-75 and Asn-69 respectively (Table 5) (Yet, et al., 1988). Overall, the
non- or partially galactosylated forms of bisecting type biantennary glycan constitutes
approximately 34% of the total glycans associated with ovomucoid. In addition, the
bisecting type glycans with 3, 4, and 5 antennae (Figure 19) could be used as control
glycans to test the specificity of the biantennary bisecting type glycans in affecting NK cell
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Figure 19: Major oligosaccharide sequences found in ovomucoid and their abbreviations
which will be used in Table 5. The arrows indicate the preference shown by Gal-T for the
Gal residues.
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Table 5: Percent distribution of the different ovomucoid glycans on its four major
glycosylation sites

% Glycan at Each Glycosylation Site

Structures

Asn-10

Asn-53

Asn-75

Asn-69

GlcNAC3Man3GlcNAC2

19

24

23

31

GalGlcNAc3Man3GlcNAC2
GaI2GlcNAc3Man3GlcNAC2

2
5

5
4

8
5

6
3

GlcNAc4Man3GlcNAc
GalGlcNAc4Man3GlcNAc
Gal2GlcNAc4Man3GlcNAC

21
5
3

25

19

10
2

8
4

20
4
3

GlcNACgMariaGlcNAc^
GalGlcNAC5Man3GlcNAc2
Gal2GlcNAc5Man3GIcNAC2

14
3

10
4

6
3

2

“

3
3
1

GlcNAc6Man3GlcNAC2
GalGlcNACeManaGlcNACj
Ga^GlcNACeMariaGlcNAc^

11
3

8
-

4
1

2
2

-

-

-

-

2

2

2
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function. We have therefore used ovomucoid to synthesize and isolate the different types of
glycans required in this study.
Another point worth noting here is that we have used glycopeptides isolated by
trypsin treatment of ovomucoid instead of free oligosaccharides. The glycopeptides were
specifically used for the following reasons:
(1) As mentioned in the discussion section of Chapter II, only appropriately presented
oligosaccharide chains seem to be active in biological assay systems. Extensive research
performed with the selectins strongly supports this hypothesis. Therefore, it was very
likely that the use of glycopeptides instead of the free oligosaccharides could help
present these glycans in a more physiological configuration whereby they could better
elicit their actual biological effects in the NK cell assays.
(2) Another advantage in using the glycopeptides was that the peptide sequence could
be tagged with reagents like fluorescein to allow for sensitive detection during the
enzymatic synthesis and isolation of the glycopeptides and possibly also during the NK
cell assays if the need arises.
Trypsin has a fairly strict specificity for proteolytically clipping peptide sequences.
This enzyme preferentially cleaves at the carboxyl terminal end of lysines or arginines
present in the protein sequence. Analysis of the ovomucoid peptide sequence as listed in the
Swiss-Prot database indicates that only four different glycopeptides could be obtained after
trypsin treatment of ovomucoid (Figure 20). The smallest glycopeptide is GP-1 which
carries the first glycosylation site (Asn-10) attached to a 7-mer. The glycosylation site at
Asn-53 is attached to a 32-mer peptide. This glycopeptide is designated as GP-2. GP-3

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

I ll

constitutes a 19-mer peptide which carries the glycosylation sites at Asn-69 and Asn-75.
The partially glycosylated site at Asn-175 is present in GP-4 (minor glycopeptide) which is
a 22-mer peptide. Since each glycosylation site carries glycan sequences as listed in Table
5, different glycoforms of each of these glycopeptides exist. We have attempted to partially
purify the bisecting type biantennary and triantennary glycans using E-PHA lectin affinity
chromatography and analyzed them for their effect in the NK cell assays.
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MAJOR GLYCOPEPTIDES
FPNATDK
(GP-1 at Asn-10; mass range 2114 - 3047 Da)
DLRPICGTDGVTYTNDCLLCAYSIEFGTNISK
(GP-2 at Asn-53; mass range 4950-5883)
ETVPMNCSSYANTTSEDGK
(GP-3 at Asn-69 and Asn-75; mass range 4459-6361)
MINOR GLYCOPEPTIDE
CNFCNAWESNGTLTLSHFGKC
(GP-4 partially filled at Asn-175; precise mass range
not yet determined)

Figure 20: The structures o f the peptide sequences attached to the three major (GP-1, GP2 and GP-3) and the minor (GP-4) glycopeptide.
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MATERIALS AND METHODS

Isolation o f Ovomucoid Glycopeptides
The general scheme used to isolate and enzymatically synthesize the galactosylated
glycopeptides is given in Figure 21. Ovomucoid (2 gm) was dissolved in 20 mL of 8 M
guanidine hydrochloride and reduced for 30 min at room temperature by adding 1.5 gm of
dithiothrietol (Corradi da Silva, et al., 1994). The reduced protein was acetylated with
iodoacetamide (3.5 gm) for 1 hr at room temperature. The reduced and acetylated protein
was dialyzed for 24 hr using 1000 molecular weight cut-off dialysis membrane against 2
mM tris-hydrochloride pH 8.0. The retained protein was lyophilized and resuspended in 2
ml 8 M guanidine hydrochloride. This solution was diluted with 20 mM Tris-hydrochloride
pH 8.0 to make the final concentration of guanidine hydrochloride 2 M. TPCK-treated
trypsin (20 mg) was added to the solution that was subsequently incubated at 37°C for 12
hr. The reaction was terminated after 4 hr by heating the solution on a boiling water bath
for 3 min. The solution was dried on a SpeedVac apparatus (Savant) and resuspended in 2
ml of 0.1 M pyridine acetate (pH 5.4) buffer. Insoluble precipitate was removed by
centrifugation. The precipitate was primarily composed of insoluble peptides as indicated
by the carbohydrate analysis using the phenol-sulfuric acid assay (Dubois et al., 1956). The
supernatant was desalted on a BioGel 2 (2.5 cm X 60 cm) column. Elution of the
glycopeptides was monitored by phenol-sulfuric acid assay and by absorbance at 280 nm.
Approximately 93% of the glycopeptides eluted in the void volume of the column.
Fractions containing the glycopeptides were pooled and dried completely at low pressure.
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Figure 21: Schematic diagram of the strategy utilized for isolation and synthesis of the
different ovomucoid glycopeptides.
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The dried sample was separated on the basis of size on a BioGel P4 (2.5 cm X 60
cm) column. The column was eluted with 0.1 M pyridine acetate (pH 5.4) and small
aliquots (10 |il) were drawn for carbohydrate analysis using the phenol sulfuric acid assay.
The high molecular weight (HMW) and low molecular weight (LMW) glycopeptides were
pooled separately and dried completely. The amount of glycopeptide obtained was
determined by phenol-sulfuric acid assay. 6 pinoles of HMW glycopeptides (assuming an
average molecular weight of 3000 Da) and 8 pmoles of LMW glycopeptides (assuming an
average molecular weight of 2500 Da) were obtained.
Galactosylation o f Ovomucoid Glycopeptides
The ovomucoid glycopeptides (5 pi) were dissolved in 600 pi of Gai-T buffer (20
mM Na-cacodylate, pH 7.0, containing 1 mM magnesium chloride and 1 mM calcium
chloride and 0.02% sodium azide). 300 pi of Gal-T buffer containing 30 pmoles of UDPGal and 1 X 107 cpm of UDP-[3H]Gal was added followed by 10 units of Gal-T (Sigma) in
100 pi Gal-T buffer. The reaction mixture was incubated for 12 h at 37°C. Another aliquot
o f Gal-T (10 units) and 10 more pmoles of UDP-Gal in 100 pi Gal-T buffer were added to
the reaction which was incubated for another 12 h at 37°C. The galactosylated
glycopeptides were separated by desalting on a BioGel P2 column as before. The elution of
the radiolabelled glycopeptides was followed by liquid scintillation. Fractions containing the
glycopeptides were pooled and dried under low pressure. A 50 pg sample of the
galactosylated glycopeptides was forwarded to Dr. Anne Dell for FAB-MS analysis.
Separation o f Galactosylated Glycopeptides by E-PHA Chromatography
To avoid over loading, 30-45 nmol of the glycopeptides were separated on the E-
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PHA-Affigel 10 (5 ml column; 6 mg lectin/ ml of gel) per run. The lectin column was
washed thoroughly with phosphate buffered saline (PBS; 20 mM sodium phosphate pH 7.4
containing 150 mM sodium chloride and 0.02% sodium azide). The glycopeptides (200 pi)
in PBS loaded on the column. The column was washed with 25 ml o f PBS and fractions
(2.5 ml) were collected. The bound glycopeptides were eluted with PBS containing 0.4 M
GalNAc. The elution of the unbound and bound glycopeptides was determined by liquid
scintillation counting of a small aliquot (20 pi) of the total fraction. After performing
several runs on the column, 750 nmoles (1.5 mg) of the glycopeptides were isolated from 3
pmoles of the galactosylated. Approximately 10-20 mg of the glycopeptides obtained after
E-PHA chromatography were analyzed by FAB-MS.
Coupling o f E-PHA to AffiG el-I0
AffiGel-10 (BioRad; 6 ml) was transferred to a 10 cm column and washed
thoroughly to remove the isopropanol used to store the gel. The gel was then equilibrated
with 0.1 M morpholinosulfonic acid buffer (MOPS), pH 5.0. 40 mg of E-PHA (EY
Laboratories) was dissolved in MOPS (3 ml) and the protein solution was added to the gel
slurry. The column was capped tightly and rotated end over end at 4°C overnight. To cap
any unreacted reactive groups on the gel, 1 M ethanolamine was added to make the final of
ethanolamine 100 mM. The column was again capped and rotated for 2 h at 4°C. The
column was then washed extensively with PBS followed by 1 M sodium chloride to remove
any non specifically bound protein. The washings were collected and analyzed for unbound
protein by determining the absorbance at 280 nm. Protein analysis indicated that 30 mg of
E-PHA (5 mg/ml of gel) was bound to the AffiGel-10. The column was reequilibrated in
PBS.
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Isolation o f Peripheral Blood N K Cells
The peripheral blood NK cells were isolated as described earlier. Briefly, 60 ml of
heparinized blood was obtained from a healthy male individual. The mononuclear cells were
separated from the red blood cells by density gradient centrifugation using Histopaque
1077 (Sigma). The mononuclear cells (10 ml) were diluted with an equal volume o f RPMT1640 media containing penicillin-streptomycin-amphotericin cocktail obtained from Gibco
and 2% fetal calf serum (RPMI-2) and centrifuged for 10 min at 250 X g using a swinging
bucket type rotor at room temperature. The pelleted cells were washed one more time with
RPMI-1640 media containing penicillin-streptomycin-amphotericin cocktail obtained from
Gibco and 10% fetal calf serum (RPMI-10) under the same conditions. The pelleted cells
were resuspended in 5 ml of RPMI-10 and loaded on 20 ml nylon wool columns presoaked
in RPMI-10 at 37°C. The nylon wool columns were prepared by taking 1.8 gm o f well
combed nylon wool in a sterile 60 ml column. The nylon wool was washed with 40 ml of
37°C RPMI-2 followed by 30 ml of 37°C RPMI-10. The column were capped and
incubated at 37°C in a 5% CO2 incubator for at least 1 hr before loading the cells.
After loading the cells on the columns, some of the media was allowed to flow
through the column to ensure that all of the cells were in contact with the nylon wool. After
approximately 5 ml of RPMI-10 was slowly added on the column, the columns were
capped and incubated at 37°C in the 5% CO2 incubator for 1 h. After incubation the non
adherent cells highly enriched in NK and T-cells were obtained by washing the nylon wool
column with 40 ml of 37°C RPMI-10. The eluted cells were collected in a 50 ml sterile
centrifuge tube. The cells were pelleted by centrifugation at 250 X g for 10 min. Pelleted
cells were washed with RPMI-2 as described before and were then resuspended in 2 ml of
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RPMI-2. Typically, approximately 80-90 million cells were obtained at this point. The cell
counting was performed by using a hemacytometer. Viability o f cells was checked by the
trypan blue dye exclusion assay. On an average more than 90% o f the cells were found to
be viable.
The cells were then subjected to negative antibody selection. A cocktail of mouse
antibodies directed against the T-and B-cell epitopes was added to the cell suspension. The
antibodies used were anti-CD3, anti-CD 14, and anti-CD 19. The cells were incubated with
these antibodies on ice for 30 min. The cell suspension was gently shaken every 5 min to
enable proper binding of the antibodies to the contaminating T- or B-cells. The antibody
bound contaminating cells were separated from the NK cells by incubating the cell
suspension with 1 ml of magnetic beads coated with goat anti-mouse IgG (BioDesign) on
ice for 30 min. Prior to use the magnetic beads were thoroughly washed five times with
RPMI-2 in a round bottom sterile plastic tube. After each wash, the beads were isolated by
holding the tube against a strong magnet (BioDesign). The media was gently pipetted out
and fresh RPMI-2 media was immediately added. The tube was taken apart from the
magnet and the beads were gently resuspended in the media.
Beads attached to the contaminating cells were removed by placing the tube against
a strong magnet as above. The media containing the NK cells was carefully pipetted out
and a fresh 1 ml aliquot of the magnetic beads to the cell suspension. The separation was
performed as described above. The cell suspension highly enriched in the NK cells was
centrifuged at 250 X g to pellet the cells. The pelleted cells were washed with RPMI-1640
media containing penicillin-streptomycin-amphotericin cocktail obtained from Gibco and
10% human AB serum (RPMI-10-AB). The pelleted cells were finally suspended in 2-3 ml

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

120

o f RPMI-10 AB. Typically 15-18 million cells were obtained at this point in the isolation.
The phenotype of the cells was checked by incubating approximately 100,000 cells in a 500
pi microcentrifuge tube with a cocktail of mouse anti human CD 16 and mouse anti-human
CD56 antibodies (5 pg/ml concentration of each antibody) on ice for 30 min. The cells
were briefly pelleted and washed three times with 400 pi of RPMI-10. The cells were
finally incubated with 5 pg/ml concentration o f FITC labeled goat anti-mouse IgG for 30
min on ice. The FITC labeled antibody was washed off by centrifugation as above. The
cells were then placed on a microscope slide and the number of FITC labeled cells in
different fields of view were counted. On an average more that 85% of the total cells were
fluorescent, indicating a high number of NK cells in the isolate.
Labeling o f K562 Cells with 51Cr
The K562 target cells were obtained from American Type Tissue Culture (ATCC).
The cells were cultured in RPMI-10 for 3 weeks before labeling. 2 million cells were used
each time for labeling. The cell counts were performed using a hemacytometer. Viability of
the cells was determined by the trypan blue dye exclusion assay. The cells used for labeling
were resuspended in 2 ml of RPMI-10 and incubated at 37°C for I hr in the presence of
100-200 mCi of Na2[51Cr]20?. After incubation the cells were washed 4 times with 10 ml of
RPMI-2 and finally once with 10 ml of RPMI-10. The pelleted cells were finally
resuspended in 4 ml o f RPMI-10.
Cytolytic Assays
The NK or LAK cytolytic assays were performed as described in an established
protocol. General paradigm used for performing these assays is shown in Figure 22.
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NK Cells Isolated From Healthy Donors

Cultured for 48 h with or
without IL-2
and Test Glycopeptide

1

I
Cultured for 48 h with IL-2

K562 Target Cells Labeled with 51Cr

NK and Labeled K562 Cells
Cultured for 4 h

Amount o f 51Cr Released
in the Medium Determined

NK and Labeled K562 Cells
and Test Glycopeptide
Cultured for 4 h

Amount o f 51Cr Released
in the Medium Determined

Figure 22: Schematic representation of the general procedure for performing the NK cell
assays in the presence of the test glycopeptides.
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The NK cells (approximately 2 million cells/ml media final concentration) were
incubated in 12-well tissue culture plates (Falcon) in the presence or absence of appropriate
amounts of the test glycopeptides for 48 h at 37°C in a 5% CO2 incubator. For the LAK
assays, the NK cells (approximately 1 million cells/ ml media, final concentration) were
cultured in 12-well tissue culture plates in the presence of 6000 IU of IL-2 (R&D Labs) in
the presence or absence of the appropriate amounts of the test glycopeptides. Cells were
cultured for 48 hr in a 5% CO2 incubator. Cytolytic assays were then performed using these
cultured NK or LAK cells. In some cases, the treated LAK cells were transferred to a 15
ml sterile centrifuge tube and washed three times with RPMI-10 to remove the
glycopeptide.
Viability of these treated NK or LAK cells was checked by the trypan blue dye
exclusion assay. The cytolytic assays were performed in 96-well round bottomed tissue
culture plates (Falcon). The total volume of each assay was 200 pi. Appropriate numbers
of the treated or untreated NK or LAK cells were added to the wells. The total volume in
each well was made 195 pi by adding the necessary amount of RPMI-10 media. This step
was followed by adding 5 ml of the 51Cr-labeled K562 (5000 cells total) targets. All of the
assay were performed in triplicates. To determine the amount of spontaneous release of the
5lCr activity from the targets, 5 pi of the labeled K562 cell suspension was added to 195 pi
o f media in six separate well. For calculating the maximal release, 5 pi of the 51Cr-labeled
target cell suspension was added to six separate wells containing 195 pi of 5% TritonX I00 in PBS. The plates were briefly centrifuged for 2 min at 1000 rpm and were
incubated

at

37°C

in

a

5%

CO2

incubator

for
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The plates were again centrifuged briefly as before. A 100 pi aliquot was carefully pipeted
out from each of the wells and was assayed for the amount of slCr in a gamma counter
(Beckmann). The amount of cytolysis was determined by the following calculation% Cytolysis= (Amount of slCr released in test) - (Amount of Spontaneous 5ICr
release)/(Amount o f maximum 5ICr release)-(Amount of Spontaneous 51Cr release) X 100.
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RESULTS

Isolation o f Ovomucoid Glycopeptides
The general scheme used to isolate and enzymatically synthesize the galactosylated
glycopeptides is given in Figure 21. Size exclusion chromatography of the ovomucoid
glycopeptides on a BioGel P4 column resulted in the isolation of HMW and LMW
glycopeptide fractions (Figure 21). It was realized that these glycopeptide fractions were
substantially contaminated with peptides. It has been previously reported that immobilized
E-PHA could be used to purify biantennary and the triantennary bisecting type glycans that
have Gaipi-4GlcNAc attached via a P1-2 linkage to the a 1-6 linked mannose of the core
(Figure 17). Such a purification step could also lead to removal of the peptide sequences
from the glycopeptides expressing these glycans. However, as mentioned before, a majority
of the glycans expressed on ovomucoid are either non- or partially galactosylated. Both the
HMW and LMW glycopeptides were therefore enzymatically galactosylated and their
glycans were analyzed by FAB-MS.
The FAB-MS profiles of the oligosaccharides linked to HMW and LMW
glycopeptides are shown in Figure 24. The structures of the glycans associated with these
glycopeptides is shown in Figure 25. Both the HMW and LMW glycans showed similar
major ions with only minor variations (Figure 24). Such minor variations are usually
observed in FAB-MS spectra due to protonation or addition of a sodium ion.
Fragmentation is also not perfectly reproducible by FAB-MS below 0.1 Da. The FAB-MS
profiles indicated that substantial galactosylation of both the glycopeptide fractions had
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Figure 23: BioGel P4 elution profile o f the trypsinized ovomucoid glycopeptides.
Ovomucoid glycopeptides were applied to a column of BioGel P4 (60 X 2.5 cm) and
eluted in 0.1 M pyridine acetate, pH 5.4. A 5 ml aliquot was obtained from each fraction
(2.8 ml) and subjected to phenol-sulfiiric acid assay (Dubois et al., 1953). Fractions 24-27
and fractions 28-37 were pooled separately and designated as HMW and LMW
respectively.
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Figure 24: FAB-MS profile of oligosaccharides derived from glycopeptides in the LMW
(Panel A) and HMW (Panel B) after reaction with Gal-T. The major peaks identified in the
text have been labeled.
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Figure 25: Structures of glycans associated with the HMW and LMW glycopeptides
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been achieved. Comparison of the abundance of the molecular ion peaks for the different
glycans indicated that approximately 60% of the HMW and 50% of the LMW
glycopeptides had been galactosylated.
Separation o f the Glycopeptides by E-PHA Column Chromatography
The biantennary and triantennary bisecting type glycans present in the HMW and
LMW fractions were isolated chromatography on a immobilized E-PHA column. On an
average 20-25% of the total [3H]Gal labeled glycopeptides loaded were found to bind to
the column (Figure 26). To obtain sufficient amounts of the material the E-PHA
chromatography was performed several times. Each run was found to be highly
reproducible. A representative profile of the separation is shown in Figure 26. The bound
(E-PHA*) and the unbound (E-PHA’) HMW and LMW glycopeptide fractions from all of
the runs were pooled and their glycans analyzed by FAB-MS. Analysis of the E-PHA*
HMW and LMW glycopeptides indicated a significant enrichment of the biantennary
bisgalactosylated (m/e -2316) and the triantennary tris-galactosylated (m/e -2765)
bisecting type glycans (Figure 27). Other significant peaks at m/e -2560 and -2118
represent the triantennary bisgalactosylated and the biantennary monogalactosylated
bisecting type glycans respectively, obtained due to under galactosylation of the
glycopeptides (Figure 27). FAB-MS spectra of the E-PHA'glycopeptides indicated the
presence of the tetraantennary (m/e —3214) and pentaantennary (m/e —3460) bisecting type
glycans in addition to the biantennary and triantennary bisecting type oligosaccharide
sequences (Figure 28). Undergalactosylated forms of the tetra and pentaantennary
oligosaccharides were also found to be present (m/e -3010 and 3255) (Figure 28).
Presence of biantennary and triantennary bisecting type glycans in the E-PHA’ fractions
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Figure 26: Separation o f HMW glycopeptides on a column of E-PHA-agarose (6.0 X 1.0
cm; 5 mg E-PHA/ ml gel). The arrow indicates the point where elution with buffer
containing 0.4 M GalNAc was initiated to remove bound glycopeptides.
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Figure 27: FAB-MS analysis of oligosaccharides obtained from LMW (Panel A) and
HMW (Panel B) glycopeptides that were bound to the E-PHA column. The doublets
observed in Panel B are due to Na+ and ET forms being in almost equimolar amount.
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Figure 28: FAB-MS profiles o f the LMW (Panel A) and HMW (Panel B) that did not bind
to the E-PHA column.
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indicated that not all of these glycans were selectively removed from the mixture. However
a substantial depletion of these glycans in the unbound fractions was definitely achieved.
Unfortunately during the isolation process the LMW E-PHA" fraction was contaminated by
bacteria and could therefore not be used in the NK cell assays. Figure 29 shows the
structures o f the glycans associated with the E-PHA+ HMW and LMW glycopeptides.
Structural Identities o f the HMW and LM W Glycopeptides
Glycopeptides used in this study were isolated after trypsin treatment of
ovomucoid. The glycopeptides obtained after this treatment were separated into two peaks
according to their size on a BioGel P4 column. It was reasoned that the glycopeptides in
the LMW fraction primarily should consist of GP-1 based on their molecular weight as
shown in Figure 20. The HMW fraction should be mainly composed of GP-2 and GP-3
(Figure 20). This distribution of the glycopeptides was confirmed by biophysical analysis of
the peptide sequences obtained after N-glycanase treatment (data not shown).
It is very likely that the E-PHA" HMW glycopeptides primarily composed of GP-2
and not GP-3. This reasoning is based on the following arguments. GP-3 carries two
glycosylation sites. Therefore presence of biantennary or triantennary bisecting type glycan
at even one o f these two sites should be sufficient for GP-3 to bind to the E-PHA column.
If GP-3 bound to E-PHA column via one o f its glycans, it is very likely that glycans present
on the other glycosylation site of this glycopeptide would be tetraantennary or
pentaantennary glycans (Table 5). However, FAB-MS analysis of the E-PHA+ glycans did
not indicate the molecular ions for such tetraantennary or pentaantennary glycans (Figure
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27 and 28). Unfortunately, due to lack of sufficient material, peptide analysis of this
fraction could not be performed.
The elution profile of the E-PHA+ HMW glycopeptides on the RCAno column
however, also indicates that GP-3 is not present in this fraction (Figure 30). The
tetraantennary and pentaantennary glycans terminated with 4 and 5 Gal residues are
expected to bind tightly to the RCA120 column, eluting off only in the presence of 0.1 M
lactose. The elution profile of the E-PHA+ HMW glycopeptides on the RCA120 column
shows three peaks (Figure 30). Peak 3 which was the most retarded is consistent with a
triantennary trisgalactosylated oligosaccharide. Peak 2 is consistent with an oligosaccharide
bearing two Gal terminals, which can be present on a triantennary bisgalactosylated or a
biantennary bisgalactosylated oligosaccharide (Figure 30). Peak 1 can be obtained from a
biantennary monogalactosylated oligosaccharide. These results are consistent with the
FAB-MS analysis of the glycans present in the E-PHA+ HMW fraction. No radioactivity
was eluted upon washing the column with 0.1 M lactose indicating that the tetraantennary
or the pentaantennary glycans were not present in this fraction (Figure 30).
If GP-3 was present in this fraction at least a small amount of the tetraantennary or
pentaanntennary glycans should have eluted in the 0.1 M lactose wash. However, no
radioactivity was eluted in the 0.1 M lactose wash (Figure 30). Therefore the FAB-MS
analysis taken together with the RCA120 affinity chromatography results clearly indicate that
the E-PHA+HMW fraction is mainly composed of GP-2.
FAB-MS analysis of the E-PHA' HMW fractions indicated the presence of both the
triantennary and biantennary bisecting type glycans. Since GP-3 did not bind to the E-PHA
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numbered positions indicated by arrows. Specific elution with 0.1 M lactose was
performed to remove all bound glycopeptides.
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column it should all have been selectively eluted in the flow through fraction. A significant
percentage of the glycans present on both the glycosylation sites of this glycopeptide
should bear triantennary and biantennary bisecting type glycans. Both the glycosylation
sites are separated by only five amino acid residues. Such close spatial arrangement of the
glycans probably results in a peculiar conformational orientation of both the glycan chains
in solution. Due to such a configuration it is possible that E-PHA is not able to recognize
the triantennary or biantennary glycans present on either one of these two glycosylation
sites. The GP-3 glycopeptide therefore remain unbound and is found predominantly in the
E-PHA" HMW fraction
Inhibition o f NK Cell And Lymphokine Activated Killer Cell Cytotoxicity By
Glycopeptides
It has been reported earlier that culturing the isolated peripheral blood NK cells
with IL-2 (interleukin-2) results in their activation. These activated cells are referred to as
the lymphokine activated killers (LAK). In this study we have determined the effect of the
E-PHA+ and the E-PHA" glycopeptides on both NK and LAK cell functions. The general
experimental paradigm used for these in vitro assays is shown in Figure 20.
E-PHA +HMW Glycopeptides Inhibit NK and LAK Function
In the first experiment, the NK cells were cultured with the different glycopeptides
(50 (iM final concentration of each glycopeptide) for 48 hr in the presence or absence of
IL-2. Trypan blue assays conducted on the cells after the 48 hr incubation period indicated
that more 90 % of the cells were viable. The labeled K562 target cells were then co
cultured with the effectors (NK and LAK) at a effector: target ratio of 50:1 for the NK
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cells and 24:1 for the LAK cells.
The results obtained indicated that the E-PHA+ HMW significantly inhibited NK
and LAK cell function (Figure 31). Marginal inhibition was observed when the effector
cells were co-cultured with E-PHA" LMW glycopeptides (Figure 31). E-PHA' HMW
glycopeptides exhibited virtually no effect on the NK and LAK cell function.
Concentration Dependent Inhibition o f LAK Activity by E-PHA* H M W Glycopeptides
Having established that the E-PHA" HMW glycopeptides suppressed NK and LAK
cell cytolytic responses it was necessary to determine the concentration dependence of this
inhibitory effect at different effector cell: target cell ratios. However, as mentioned before
only a small amount (1.5 mg) of the E-PHA" HMW glycopeptide could be isolated. Not
enough material was available to perform experiments with both the NK and LAK cells.
We therefore focused on obtaining data using LAK cells. The LAK’s were cultured for 48
hr with 20, 10, 5, and 1 pM final concentration of the E-PHA" HMW glycopeptide. Assays
were performed at effector celhtarget cell ratios of 24:1, 12:1, 6:1, and 3:1. The data
obtained clearly showed a concentration dependent inhibition of the LAK responses by the
E-PHA" HMW glycopeptides (Figure 32). These results suggest that 50% inhibition of the
LAK cytolysis can be achieved between 5 pM and 10 pM concentration of the E-PHA"
HMW glycopeptides (Figure 32).
E-PHA* HMW Glycopeptides Inhibit The Activation Events O f LAK Cells
In all of the experiments mentioned above, the LAK or NK cells were cultured with
the glycopeptides for 48 hr prior to incubation with the target cells. The next experiment
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was therefore designed to study the effect of the glycopeptides when added during the 4 hr
cytolytic assay. The experimental paradigm used for this experiment is briefly shown in
Figure 22. Assays were performed with LAK cells at effectontarget cell ratios o f 12:1 and
6:1. The effector and target cells were co-cultured for 4 hours in the presence of the EPHA" HMW, E-PHA' HMW, and E-PHA" LMW glycopeptides at a final concentration of
20 mM. In separate experiments, the LAK cells were also incubated with these
glycopeptides for 48 h. The glycopeptides were removed by centrifuging the LAK’s and
washing them twice with RPMI-10 media. The washed LAK cells were mixed with the
target cells at effectontarget cell ratios of 12:1 and 6:1.
Glycopeptides tested had very little effect on the LAK responses when added
during the 4 hr cytolytic assay (Figure 33). Washing of the LAK’s prior to performing the
cytolytic assay had no significant effect on difference in the inhibition profiles of the
glycopeptides (Figure 33). The E-PHA" HMW glycopeptides were again found to potently
inhibit LAK mediated cytolysis under these conditions (Figure 33).
Ovomucoid and Conalbtimin Have No effect On NK Cell Mediated Cytolysis
As a control experiment we determined if incubation with either conalbumin or
ovomucoid had any effect on NK cell function. These glycoproteins had no inhibitory effect
on NK cell function at this concentration when incubated for 48 hr with the NK cells at 100
|j.g/ml concentration (Figure 34). In fact there appeared to be a slight stimulatory effect
with conalbumin (Figure 34). Another control experiment would have been to determine if
galactosylated ovomucoid or conalbumin was capable of affecting NK cell function.
However, incubation of 1 mg of each glycoprotein with 2 units o f bovine milk
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Figure 33: Addition of the E-PHA+ HMW glycopeptides during the 4 h cytolytic assay
does not result in inhibition of NK cell function. For 4 h comparison points, NK cells were
stimulated with EL-2 for 48 h. Target cells were added to obtain the appropriate EC-TC
ratio along with glycopeptides at a final concentration of 20 pM for the assay. In the
+Wash comparisons, NK cells were incubated with IL-2 for 48 h with glycopeptides. The
cells were washed 2 times to remove glycopeptide and IL-2 and subjected to the cytolytic
assay at the given target ratios. Each assay was performed in triplicates.
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galactosyltransferase, 3 mM UDP-Gal and 1 X 106 cpm of UDP-[3H]GaI under optimal
conditions for galactosylation (Barker, et al., 1972) did not lead to any detectable
galactosylation of either ovomucoid or conalbumin. Therefore the potential effect of
galactosylated ovomucoid and conalbumin on NK cell activity could not be tested.
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DISCUSSION

Protection of the developing human from the maternal immune response is a vital
function in reproduction (Hegde, 1991). Similarly, defending the human spermatozoa and
eggs from potential immune responses would also be beneficial for the propagation of the
species. As described in Chapter HI, we have recently proposed the Hu-FEDS hypothesis
which states that specific glycoconjugates expressed during pregnancy and on the surface
of the male and the female gametes are responsible in suppressing the female’s immune
responses thereby allowing fertilization and implantation to occur. In the current study we
provide preliminary evidence that specific glycans can inhibit immune cell function.
Only E-PHA+HM W Glycopeptides Inhibit NK/LAK Cell Function
The NK and LAK cell assays indicated that the E-PHA" HMW glycopeptides were
potent inhibitors of cytolytic responses. These results indicated that either the biantennary
or triantennary bisecting type glycans or both were able to inhibit NK or LAK activities.
The E-PHA' HMW fractions which contained a mixture of the tetraantennary and
pentaantennary glycans in addition to triantennary and biantennary bisecting type glycans
did not have any effect on NK or LAK cell mediated cytolytic responses. As mentioned
before, the triantennary and the biantennary bisecting type glycans detected in the E-PHA'
HMW fraction are probably present on the GP-3 glycopeptide. The close proximity of the
two glycosylation sites present in this glycopeptide probably results in these glycans not
being recognized by E-PHA. It is likely that due to similar reasons, the triantennary and
biantennary glycans present on GP-3 are unable to interact with the inhibitory cell surface
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receptors expressed on the NK or LAK cells. Therefore, although the triantennary or
biantennary bisecting type glycans are present the E-PHA" HMW fraction is not capable of
inhibiting NK or LAK cell mediated cytolytic responses. The inability of the E-PHA- HMW
glycopeptides to suppress NK or LAK cell activities also strongly suggests that the
tetraantennary or pentaantennary bisecting type glycans present in this fraction are not
inhibitory.
Another interesting observation made in these studies was that although the EPHA+ LMW fraction contained the triantennary and biantennary bisecting type glycans,
these glycopeptides were not as potent in inhibiting the NK or LAK cell responses as the EPHA+HMW glycopeptides. The oligosaccharides of the LMW glycopeptides are carried on
a 7 amino acid peptide, the E-PHA+ HMW glycans are presented on a 32 amino acid
peptide sequence. It is therefore likely that the inhibitory receptors present on the NK or
LAK cells recognize the bisecting type glycans in the context o f their peptide sequences.
Presentation of these glycans on a longer rather than short peptide sequence results in a
better recognition of the glycans by these receptors leading to a more potent inhibition of
NK or LAK cell function.
The results presented in this study therefore indicate that the inhibitory receptors
expressed on the NK or LAK cells have a strict specificity for the triantennary or
biantennary bisecting type glycans. These receptors are not affected by the tetraantennary
or pentaantennary bisecting type glycans. Furthermore, it is also likely that presentation of
the inhibitory glycans on an appropriate peptide platform may be absolutely essential for
potently abrogating the NK or LAK cell responses. Further studies are absolutely required
for clearly characterizing the details of the inhibitory effects exhibited by these
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glycopeptides.
It is likely that glycoconjugates expressing the bisecting type may play an important
role in inhibiting the maternal immune responses. During pregnancy, 2-3 weeks prior to
term, a clinical development known as cervical ripening is observed (Romero, 1994). This
process is accompanied by a substantial influx of inflammatory cell types into the cervix and
decidua, the cause of this influx is not known. It is however interesting to note that this
recruitment of the immune effector cells correlates temporally to the loss of Gd-A synthesis
and also the changes in the glycosylation pattern of AFP. It is therefore also possible that
removal of these suppressive factors plays a role during child birth. It would therefore be
significant to study if an untimely removal of such glycoconjugates during pregnancy could
lead to premature labor in some clinical cases.
Expression o f the Bisecting Type Sequences on HIV
There is evidence indicating that the human immunodeficiency virus (HIV) may also
be acquiring the biantennary bisecting type glycans. Infection of human H9 lymphoblastoid
cells with HIV yields the viral glycoprotein gpl20. Analysis o f the V-linked glycans
associated with this form of gpl20 indicates that approximately 11% of the glycans carry
the bisecting type biantennary glycans (Mizouchi et al., 1990). It would be interesting to
study if the expression of this glycan sequence helps the virus to evade NIC cell mediated
responses.
Glycosylation o f H IV Glycoproteins
The gpl20 glycoprotein is a heavily glycosylated protein with up to 20 total Nlinked and an undetermined number of (9-linked glycosylation sites. Thus a vast diversity of
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oligosaccharide sequences can be expressed on this glycoprotein. A significant question
that can be asked here is does the expression of such diverse glycans help HEV to induce
immunosuppressive effects in the human? We have recently proposed a model that could
possibly explain role of glycoconjugates expressed on the HIV glycoproteins in mediating
the potent immunosuppressive effects observed in infected individuals.
HIV is unique because of its ability to preferentially infect the T-lymphocytes
(Barre-Sinoussi et al., 1983). The virus therefore has an uncontrolled access to the
glycosylation machinery of the T-cells. HTV glycoproteins could therefore acquire glycan
sequences that may be exclusive to the T-cell glycoproteins. A growing number of
receptors expressed on the immune cells have been shown be lectins. Some of these lectin
receptors like the selectins bind only to the carbohydrate ligands (Varki, 1994)whereas
others like CD22 recognize the carbohydrates in the context of the protein structures to
which the glycans are attached (Hanasaki et al., 1994; Powell and Varki, 1994).
Thus after infection, the HIV glycoproteins could acquire the oligosaccharide
sequences that are usually found on the T-cell glycoproteins. Expression of such
oligosaccharides could therefore enable the virus to inhibit or evoke a particular immune or
inflammatory response via lectin receptors that only require recognition of the
carbohydrate. Several reports also indicate that the HTV proteins share significant structural
similarities with some of the T-cell proteins (Golding et al., 1988; 1989; Imberti et al.,
1991; Dalgleish et al., 1992; Levy, 1993). Glycosylation of such HTV proteins in the T-cell
could therefore also result in their recognition by receptors that require both the
carbohydrate and the protein structures together.
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Such molecular mimicry could be extremely important for HIV virus during the
initial stages of infection when the major goal for the virus is establish itself in the T-cells.
Because of its high rate of mutation, infected T-cells could produce mutant viruses that
could either be destroyed or propagate depending on their ability to infect other cells and
evade or misdirect the immune response. The high mutational rate in the viral genome
coupled with the selective pressures applied by the host’s immune system could therefore
lead to the production of mutant virions that could completely defeat the host’s immune
system.
Our hypothesis therefore predicts that by acquiring the T-cell glycans at least a
fraction of the HIV infected cells that closely mimic the T-cell glycoproteins could evade
immune responses directed against them. The viruses that survive the immune attacks could
then be able to utilize their glycans to interact with the carbohydrate receptors of other
cells, enabling them to infect a variety o f different immune and non-immune cell types.
Finally, soluble or cell surface associated viral glycoproteins carrying the appropriate chains
could inhibit normal immune function or induce aberrant immune responses. These
mechanisms could eventually lead to the generation of a variant set of viruses that could
overwhelm the immune system, leading to the development of the acquired
immunodeficiency syndrome (AIDS).
Glycoconjugate M ediated Recognition o f S elf
Finally the results obtained in our experiments with the NK and LAK cells have
clearly indicated that the bisecting type biantennary or triantennary glycans can inhibit their
cellular responses. However, the exact mechanisms by which these glycopeptides are able
to abrogate the NK or LAK cell activities are not known at this point. However, as
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mentioned earlier, many different KIR and KAR expressed on the surfaces o f the NK cells
carry C-type lectin domains (Moretta, et al., 1997). It is possible that the some KIR may
bind to the bisecting type glycans thereby triggering a signaling cascade that results in the
inhibition of NK cell function. As mentioned earlier, NK cells recognize the absence of
MHC molecules on the surface of their target cells (Moretta, et al., 1992). However, we
believe it is likely that the NK cells may also be looking for the expression of the
appropriate glycoconjugates on the targets. The lack of expression of such glycoconjugates
may result in induction of the cytolytic responses against the target cells. Therefore, the
expression of these appropriate glycoconjugates may in turn be a signal to the NK or LAK
cells to recognize the target cell as self. It would be interesting to study if specific
glycoconjugates could also suppress responses mediated by other immune cell types. If so,
recognition of self could be mediated not only by the MHC system but also by the
expression of cell surface associated glycoconjugates.
Conclusion
In this chapter we have provided preliminary evidence suggesting that specific
exposure of the NK or LAK cells to specific glycoconjugates could inhibit their cellular
responses. More work will definitely be needed to characterize the exact mechanism
involved in mediating such glycoconjugate mediated suppressive effects. However the
occurrence of the bisecting type glycans on glycoproteins like AFP and on HTV gpl20
strongly suggests that suppression of cellular immunity by glycoconjugates may be playing
a significant physiological role in pregnancy and also in various pathological states. These
preliminary studies may lead to new approaches for understanding the human immune and
reproductive systems and may help in providing better avenues to combat infections.
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CHAPTER V
CONCLUSION

Many previous reports have suggested that glycoconjugates could play important
roles in human gamete binding interactions and also in various immune cell functions
(Gahmberg et al., 1992). Substantial evidence obtained in the mouse system clearly
indicates that the oligosaccharides expressed on the surface of the ZP are absolutely
essential for mediating sperm binding (Wassarman, 1990). Unambiguous evidence for the
involvement of the human ZP oligosaccharides in mediating gamete adhesion however has
not been available so far. The experiments conducted in this study strongly support such a
role for the ZP oligosaccharides. We have performed carefully controlled studies to
demonstrate that glycoconjugates or oligosaccharides bearing restricted structures are able
to potently block human sperm-ZP binding in an in vitro assay system. Such a specificity
for the oligosaccharide structure clearly indicates that the egg binding protein expressed on
the surface of the sperm is recognizing a oligosaccharide ligand present on the ZP. Using
subtle chemical and enzymatic modification that affect only the ZP oligosaccharides, we
have shown that sperm binding to these treated ZP can be significantly affected. Periodate
treatment of the ZP under mild conditions that affect only the terminal sialic acid residues
results in approximately 30% inhibition of sperm binding. Similarly periodate oxidation of
the ZP under conditions that affects all of the terminal sugars, results in a significant 40%
inhibition of sperm binding. Both these experiments indicate that chemical modifications of
the terminal ZP oligosaccharides substantially affects human sperm-ZP binding. We have
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also shown that removal of the terminal sialic acids and also some of the terminal
polylactosamine chains significantly increases sperm binding to the ZP indicating that the
egg binding receptor present on the human sperm may be recognizing some internal
oligosaccharide motifs. Removal of the outer glycans helps the receptor to better recognize
the internal oligosaccharides.
Periodate oxidation experiments conducted on neuraminidase treated ZP perhaps
provide the most compelling evidence supporting the role of the ZP oligosaccharides in
mediating sperm binding. Mild periodate treatment of neuraminidase treated ZP results in a
almost complete loss of sperm binding. It is likely that the removal of the terminal sialic
acids results in complete exposure of the internal glycan residues. However treatment of
these residues with periodate results in their total chemical modifications which are not
recognized by the egg binding protein present on the sperm.
Collectively all of this data unambiguously demonstrates the role o f the ZP
oligosaccharides in mediating initial human sperm-egg binding. We are pursuing different
approaches to clearly identify the glycan structures that are required to mediate this
adhesion event. Identification of such glycan sequences would greatly help in identification
of the egg binding protein expressed on human sperm. A better understanding of these
processes would lead to the development of novel contraceptives and also in the devising
better strategies for treatment of at least some causes of infertility.
Finally our studies have also indicated that a considerable overlap likely exists
between the carbohydrate ligands involved in human gamete binding and in the mediating
various immune cell functions. On this basis we have proposed that specific expression of
immunosuppressive glycoconjugates occurs during pregnancy. Such temporal expression of
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these glycoconjugates may be absolutely required to protect the human embryo/fetus from
the maternal immune responses. This paradigm is referred to as the Human fetoembryonic
defense system hypothesis (Hu-FEDS). It is proposed that the human gametes and other
glycoconjugates expressed during pregnancy specifically acquire glycans that potently
suppress the cell mediated cytolytic responses of the maternal immune system. The first
preliminary evidence for the existence of such a glycoconjugate based immunosuppressive
system is provided in this study. First we show that the human gametes express the
bisecting type GlcNAc sequences which have been previously suggested to inhibit NK cell
mediated responses. In chapter IV we have synthesized and isolated the bisecting type
glycopeptides and shown that they can potently inhibit NK cell mediated cytolysis of the
target K562 cells.
AFT* and other glycoproteins expressed during pregnancy have been previously
shown to carry the bisecting type glycans (Tsuchida, et al., 1984). We therefore believe
that specific expression of such glycans on these glycoproteins may play an important role
in the immunoprotection of the embryo/fetus. In addition many different studies have
indicated that the expression of the bisecting type and other unusual glycans on the surfaces
of parasites (Mizouchi et al., 1990; Kang, et al., 1993). Expression of the bisecting type
glycans has also been demonstrated on the HIV glycoprotein gpl20. It may therefore be
very likely that these different pathogens may be co-opting the same glycoconjugate based
system of immunosuppression that is used to protect the fetus to evade the hosts immune
responses. Further studies are currently in progress to determine the exact mechanisms by
which these glycopeptides inhibit the NK cell responses. However, the data obtained from
these studies may have paved a way for developing new strategies to understanding
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fetomatemal tolerance and the ability of different pathogens to circumvent the immune
response of the host.
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